{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "df1=pd.read_csv('df_Apple.csv')\n",
    "df2=pd.read_csv('df_axalta.csv')\n",
    "df3=pd.read_csv('df_Capgemini.csv')\n",
    "df4=pd.read_csv('df_michelin.csv')\n",
    "df5=pd.read_csv('df_NIO.csv')\n",
    "df6=pd.read_csv('df_PWCO.csv')\n",
    "df7=pd.read_csv('df_TARKETT.csv')\n",
    "df8=pd.read_csv('df_XPeng.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(245, 13)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Breakdown</th>\n",
       "      <th>ttm</th>\n",
       "      <th>9/29/2020</th>\n",
       "      <th>9/29/2019</th>\n",
       "      <th>9/29/2018</th>\n",
       "      <th>9/29/2017</th>\n",
       "      <th>finStat</th>\n",
       "      <th>group_name</th>\n",
       "      <th>sector</th>\n",
       "      <th>12/30/2020</th>\n",
       "      <th>12/30/2019</th>\n",
       "      <th>12/30/2018</th>\n",
       "      <th>12/30/2017</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Total Revenue</td>\n",
       "      <td>347,155,000</td>\n",
       "      <td>274,515,000</td>\n",
       "      <td>260,174,000</td>\n",
       "      <td>265,595,000</td>\n",
       "      <td>229,234,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Cost of Revenue</td>\n",
       "      <td>204,804,000</td>\n",
       "      <td>169,559,000</td>\n",
       "      <td>161,782,000</td>\n",
       "      <td>163,756,000</td>\n",
       "      <td>141,048,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Gross Profit</td>\n",
       "      <td>142,351,000</td>\n",
       "      <td>104,956,000</td>\n",
       "      <td>98,392,000</td>\n",
       "      <td>101,839,000</td>\n",
       "      <td>88,186,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Operating Expense</td>\n",
       "      <td>42,413,000</td>\n",
       "      <td>38,668,000</td>\n",
       "      <td>34,462,000</td>\n",
       "      <td>30,941,000</td>\n",
       "      <td>26,842,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Operating Income</td>\n",
       "      <td>99,938,000</td>\n",
       "      <td>66,288,000</td>\n",
       "      <td>63,930,000</td>\n",
       "      <td>70,898,000</td>\n",
       "      <td>61,344,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           Breakdown          ttm    9/29/2020    9/29/2019    9/29/2018  \\\n",
       "0      Total Revenue  347,155,000  274,515,000  260,174,000  265,595,000   \n",
       "1    Cost of Revenue  204,804,000  169,559,000  161,782,000  163,756,000   \n",
       "2       Gross Profit  142,351,000  104,956,000   98,392,000  101,839,000   \n",
       "3  Operating Expense   42,413,000   38,668,000   34,462,000   30,941,000   \n",
       "4   Operating Income   99,938,000   66,288,000   63,930,000   70,898,000   \n",
       "\n",
       "     9/29/2017           finStat group_name      sector 12/30/2020 12/30/2019  \\\n",
       "0  229,234,000  income statement      Apple  Technology        NaN        NaN   \n",
       "1  141,048,000  income statement      Apple  Technology        NaN        NaN   \n",
       "2   88,186,000  income statement      Apple  Technology        NaN        NaN   \n",
       "3   26,842,000  income statement      Apple  Technology        NaN        NaN   \n",
       "4   61,344,000  income statement      Apple  Technology        NaN        NaN   \n",
       "\n",
       "  12/30/2018 12/30/2017  \n",
       "0        NaN        NaN  \n",
       "1        NaN        NaN  \n",
       "2        NaN        NaN  \n",
       "3        NaN        NaN  \n",
       "4        NaN        NaN  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfs=pd.concat([df1,df2,df3,df4,df5,df6,df7,df8], ignore_index=True)\n",
    "print(dfs.shape)\n",
    "dfs.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>elt</th>\n",
       "      <th>IFRS_tag</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Accounting profit</td>\n",
       "      <td>ifrs-full_AccountingProfit_label</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Accumulated increase (decrease) in fair value ...</td>\n",
       "      <td>ifrs-full_AccumulatedChangesInFairValueOfFinan...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Accumulated increase (decrease) in fair value ...</td>\n",
       "      <td>ifrs-full_AccumulatedChangesInFairValueOfLoanO...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Acquisitions through business combinations, bi...</td>\n",
       "      <td>ifrs-full_AcquisitionsThroughBusinessCombinati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Acquisitions through business combinations, in...</td>\n",
       "      <td>ifrs-full_AcquisitionsThroughBusinessCombinati...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 elt  \\\n",
       "0                                  Accounting profit   \n",
       "1  Accumulated increase (decrease) in fair value ...   \n",
       "2  Accumulated increase (decrease) in fair value ...   \n",
       "3  Acquisitions through business combinations, bi...   \n",
       "4  Acquisitions through business combinations, in...   \n",
       "\n",
       "                                            IFRS_tag  \n",
       "0                   ifrs-full_AccountingProfit_label  \n",
       "1  ifrs-full_AccumulatedChangesInFairValueOfFinan...  \n",
       "2  ifrs-full_AccumulatedChangesInFairValueOfLoanO...  \n",
       "3  ifrs-full_AcquisitionsThroughBusinessCombinati...  \n",
       "4  ifrs-full_AcquisitionsThroughBusinessCombinati...  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_tag=pd.read_csv('df_lab_IFRS_full_2021.csv')\n",
    "df_tag.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "dfs.rename(columns={'Breakdown':'elt'}, inplace=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>elt</th>\n",
       "      <th>ttm</th>\n",
       "      <th>9/29/2020</th>\n",
       "      <th>9/29/2019</th>\n",
       "      <th>9/29/2018</th>\n",
       "      <th>9/29/2017</th>\n",
       "      <th>finStat</th>\n",
       "      <th>group_name</th>\n",
       "      <th>sector</th>\n",
       "      <th>12/30/2020</th>\n",
       "      <th>12/30/2019</th>\n",
       "      <th>12/30/2018</th>\n",
       "      <th>12/30/2017</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Total Revenue</td>\n",
       "      <td>347,155,000</td>\n",
       "      <td>274,515,000</td>\n",
       "      <td>260,174,000</td>\n",
       "      <td>265,595,000</td>\n",
       "      <td>229,234,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Cost of Revenue</td>\n",
       "      <td>204,804,000</td>\n",
       "      <td>169,559,000</td>\n",
       "      <td>161,782,000</td>\n",
       "      <td>163,756,000</td>\n",
       "      <td>141,048,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Gross Profit</td>\n",
       "      <td>142,351,000</td>\n",
       "      <td>104,956,000</td>\n",
       "      <td>98,392,000</td>\n",
       "      <td>101,839,000</td>\n",
       "      <td>88,186,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Operating Expense</td>\n",
       "      <td>42,413,000</td>\n",
       "      <td>38,668,000</td>\n",
       "      <td>34,462,000</td>\n",
       "      <td>30,941,000</td>\n",
       "      <td>26,842,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Operating Income</td>\n",
       "      <td>99,938,000</td>\n",
       "      <td>66,288,000</td>\n",
       "      <td>63,930,000</td>\n",
       "      <td>70,898,000</td>\n",
       "      <td>61,344,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 elt          ttm    9/29/2020    9/29/2019    9/29/2018  \\\n",
       "0      Total Revenue  347,155,000  274,515,000  260,174,000  265,595,000   \n",
       "1    Cost of Revenue  204,804,000  169,559,000  161,782,000  163,756,000   \n",
       "2       Gross Profit  142,351,000  104,956,000   98,392,000  101,839,000   \n",
       "3  Operating Expense   42,413,000   38,668,000   34,462,000   30,941,000   \n",
       "4   Operating Income   99,938,000   66,288,000   63,930,000   70,898,000   \n",
       "\n",
       "     9/29/2017           finStat group_name      sector 12/30/2020 12/30/2019  \\\n",
       "0  229,234,000  income statement      Apple  Technology        NaN        NaN   \n",
       "1  141,048,000  income statement      Apple  Technology        NaN        NaN   \n",
       "2   88,186,000  income statement      Apple  Technology        NaN        NaN   \n",
       "3   26,842,000  income statement      Apple  Technology        NaN        NaN   \n",
       "4   61,344,000  income statement      Apple  Technology        NaN        NaN   \n",
       "\n",
       "  12/30/2018 12/30/2017  \n",
       "0        NaN        NaN  \n",
       "1        NaN        NaN  \n",
       "2        NaN        NaN  \n",
       "3        NaN        NaN  \n",
       "4        NaN        NaN  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfs.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "dfs['elt']=dfs['elt'].str.lower()\n",
    "df_tag['elt']=df_tag['elt'].str.lower()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "252\n",
      "245\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>elt</th>\n",
       "      <th>ttm</th>\n",
       "      <th>9/29/2020</th>\n",
       "      <th>9/29/2019</th>\n",
       "      <th>9/29/2018</th>\n",
       "      <th>9/29/2017</th>\n",
       "      <th>finStat</th>\n",
       "      <th>group_name</th>\n",
       "      <th>sector</th>\n",
       "      <th>12/30/2020</th>\n",
       "      <th>12/30/2019</th>\n",
       "      <th>12/30/2018</th>\n",
       "      <th>12/30/2017</th>\n",
       "      <th>IFRS_tag</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>total revenue</td>\n",
       "      <td>347,155,000</td>\n",
       "      <td>274,515,000</td>\n",
       "      <td>260,174,000</td>\n",
       "      <td>265,595,000</td>\n",
       "      <td>229,234,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ifrs-full_Revenue_totalLabel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>cost of revenue</td>\n",
       "      <td>204,804,000</td>\n",
       "      <td>169,559,000</td>\n",
       "      <td>161,782,000</td>\n",
       "      <td>163,756,000</td>\n",
       "      <td>141,048,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>gross profit</td>\n",
       "      <td>142,351,000</td>\n",
       "      <td>104,956,000</td>\n",
       "      <td>98,392,000</td>\n",
       "      <td>101,839,000</td>\n",
       "      <td>88,186,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ifrs-full_GrossProfit_label</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>gross profit</td>\n",
       "      <td>142,351,000</td>\n",
       "      <td>104,956,000</td>\n",
       "      <td>98,392,000</td>\n",
       "      <td>101,839,000</td>\n",
       "      <td>88,186,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ifrs-full_GrossProfit_netLabel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>operating expense</td>\n",
       "      <td>42,413,000</td>\n",
       "      <td>38,668,000</td>\n",
       "      <td>34,462,000</td>\n",
       "      <td>30,941,000</td>\n",
       "      <td>26,842,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ifrs-full_OperatingExpense_label</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>operating income</td>\n",
       "      <td>99,938,000</td>\n",
       "      <td>66,288,000</td>\n",
       "      <td>63,930,000</td>\n",
       "      <td>70,898,000</td>\n",
       "      <td>61,344,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>net non operating interest income expense</td>\n",
       "      <td>345,000</td>\n",
       "      <td>890,000</td>\n",
       "      <td>1,385,000</td>\n",
       "      <td>2,446,000</td>\n",
       "      <td>2,878,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>other income expense</td>\n",
       "      <td>577,000</td>\n",
       "      <td>-87,000</td>\n",
       "      <td>422,000</td>\n",
       "      <td>-441,000</td>\n",
       "      <td>-133,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>pretax income</td>\n",
       "      <td>100,860,000</td>\n",
       "      <td>67,091,000</td>\n",
       "      <td>65,737,000</td>\n",
       "      <td>72,903,000</td>\n",
       "      <td>64,089,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>tax provision</td>\n",
       "      <td>14,058,000</td>\n",
       "      <td>9,680,000</td>\n",
       "      <td>10,481,000</td>\n",
       "      <td>13,372,000</td>\n",
       "      <td>15,738,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>net income common stockholders</td>\n",
       "      <td>86,802,000</td>\n",
       "      <td>57,411,000</td>\n",
       "      <td>55,256,000</td>\n",
       "      <td>59,531,000</td>\n",
       "      <td>48,351,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>diluted ni available to com stockholders</td>\n",
       "      <td>86,802,000</td>\n",
       "      <td>57,411,000</td>\n",
       "      <td>55,256,000</td>\n",
       "      <td>59,531,000</td>\n",
       "      <td>48,351,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>basic eps</td>\n",
       "      <td>-</td>\n",
       "      <td>3.31</td>\n",
       "      <td>2.99</td>\n",
       "      <td>3.00</td>\n",
       "      <td>2.32</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>diluted eps</td>\n",
       "      <td>-</td>\n",
       "      <td>3.28</td>\n",
       "      <td>2.97</td>\n",
       "      <td>2.98</td>\n",
       "      <td>2.30</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>basic average shares</td>\n",
       "      <td>-</td>\n",
       "      <td>17,352,119</td>\n",
       "      <td>18,471,336</td>\n",
       "      <td>19,821,508</td>\n",
       "      <td>20,868,968</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>diluted average shares</td>\n",
       "      <td>-</td>\n",
       "      <td>17,528,214</td>\n",
       "      <td>18,595,652</td>\n",
       "      <td>20,000,436</td>\n",
       "      <td>21,006,768</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>total operating income as reported</td>\n",
       "      <td>99,938,000</td>\n",
       "      <td>66,288,000</td>\n",
       "      <td>63,930,000</td>\n",
       "      <td>70,898,000</td>\n",
       "      <td>61,344,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>total expenses</td>\n",
       "      <td>247,217,000</td>\n",
       "      <td>208,227,000</td>\n",
       "      <td>196,244,000</td>\n",
       "      <td>194,697,000</td>\n",
       "      <td>167,890,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>net income from continuing &amp; discontinued oper...</td>\n",
       "      <td>86,802,000</td>\n",
       "      <td>57,411,000</td>\n",
       "      <td>55,256,000</td>\n",
       "      <td>59,531,000</td>\n",
       "      <td>48,351,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>normalized income</td>\n",
       "      <td>86,802,000</td>\n",
       "      <td>57,411,000</td>\n",
       "      <td>55,256,000</td>\n",
       "      <td>59,531,000</td>\n",
       "      <td>48,351,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>interest income</td>\n",
       "      <td>2,952,000</td>\n",
       "      <td>3,763,000</td>\n",
       "      <td>4,961,000</td>\n",
       "      <td>5,686,000</td>\n",
       "      <td>5,201,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ifrs-full_RevenueFromInterest_label</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>interest expense</td>\n",
       "      <td>2,607,000</td>\n",
       "      <td>2,873,000</td>\n",
       "      <td>3,576,000</td>\n",
       "      <td>3,240,000</td>\n",
       "      <td>2,323,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ifrs-full_InterestExpense_label</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>net interest income</td>\n",
       "      <td>345,000</td>\n",
       "      <td>890,000</td>\n",
       "      <td>1,385,000</td>\n",
       "      <td>2,446,000</td>\n",
       "      <td>2,878,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>ebit</td>\n",
       "      <td>103,467,000</td>\n",
       "      <td>69,964,000</td>\n",
       "      <td>69,313,000</td>\n",
       "      <td>76,143,000</td>\n",
       "      <td>66,412,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>ebitda</td>\n",
       "      <td>114,464,000</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>-</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>reconciled cost of revenue</td>\n",
       "      <td>204,804,000</td>\n",
       "      <td>169,559,000</td>\n",
       "      <td>161,782,000</td>\n",
       "      <td>163,756,000</td>\n",
       "      <td>141,048,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>reconciled depreciation</td>\n",
       "      <td>10,997,000</td>\n",
       "      <td>11,056,000</td>\n",
       "      <td>12,547,000</td>\n",
       "      <td>10,903,000</td>\n",
       "      <td>10,157,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>net income from continuing operation net minor...</td>\n",
       "      <td>86,802,000</td>\n",
       "      <td>57,411,000</td>\n",
       "      <td>55,256,000</td>\n",
       "      <td>59,531,000</td>\n",
       "      <td>48,351,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>normalized ebitda</td>\n",
       "      <td>114,464,000</td>\n",
       "      <td>81,020,000</td>\n",
       "      <td>81,860,000</td>\n",
       "      <td>87,046,000</td>\n",
       "      <td>76,569,000</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>tax rate for calcs</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>tax effect of unusual items</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Apple</td>\n",
       "      <td>Technology</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>total revenue</td>\n",
       "      <td>4,291,800</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Axalta Coating Systems Ltd.</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>3,737,600</td>\n",
       "      <td>4,482,200</td>\n",
       "      <td>4,696,000</td>\n",
       "      <td>4,377,000</td>\n",
       "      <td>ifrs-full_Revenue_totalLabel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>cost of revenue</td>\n",
       "      <td>2,749,200</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Axalta Coating Systems Ltd.</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>2,457,900</td>\n",
       "      <td>2,917,900</td>\n",
       "      <td>3,106,300</td>\n",
       "      <td>2,779,600</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>gross profit</td>\n",
       "      <td>1,542,600</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Axalta Coating Systems Ltd.</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>1,279,700</td>\n",
       "      <td>1,564,300</td>\n",
       "      <td>1,589,700</td>\n",
       "      <td>1,597,400</td>\n",
       "      <td>ifrs-full_GrossProfit_label</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>gross profit</td>\n",
       "      <td>1,542,600</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Axalta Coating Systems Ltd.</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>1,279,700</td>\n",
       "      <td>1,564,300</td>\n",
       "      <td>1,589,700</td>\n",
       "      <td>1,597,400</td>\n",
       "      <td>ifrs-full_GrossProfit_netLabel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>operating expense</td>\n",
       "      <td>994,700</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Axalta Coating Systems Ltd.</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>974,200</td>\n",
       "      <td>1,076,100</td>\n",
       "      <td>1,147,600</td>\n",
       "      <td>1,164,200</td>\n",
       "      <td>ifrs-full_OperatingExpense_label</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>operating income</td>\n",
       "      <td>547,900</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Axalta Coating Systems Ltd.</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>305,500</td>\n",
       "      <td>488,200</td>\n",
       "      <td>442,100</td>\n",
       "      <td>433,200</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>net non operating interest income expense</td>\n",
       "      <td>-144,200</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Axalta Coating Systems Ltd.</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>-149,900</td>\n",
       "      <td>-162,600</td>\n",
       "      <td>-159,600</td>\n",
       "      <td>-147,000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>other income expense</td>\n",
       "      <td>-26,300</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>income statement</td>\n",
       "      <td>Axalta Coating Systems Ltd.</td>\n",
       "      <td>Basic Materials</td>\n",
       "      <td>-33,400</td>\n",
       "      <td>4,400</td>\n",
       "      <td>-15,000</td>\n",
       "      <td>-96,600</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  elt          ttm  \\\n",
       "0                                       total revenue  347,155,000   \n",
       "1                                     cost of revenue  204,804,000   \n",
       "2                                        gross profit  142,351,000   \n",
       "3                                        gross profit  142,351,000   \n",
       "4                                   operating expense   42,413,000   \n",
       "5                                    operating income   99,938,000   \n",
       "6           net non operating interest income expense      345,000   \n",
       "7                                other income expense      577,000   \n",
       "8                                       pretax income  100,860,000   \n",
       "9                                       tax provision   14,058,000   \n",
       "10                     net income common stockholders   86,802,000   \n",
       "11           diluted ni available to com stockholders   86,802,000   \n",
       "12                                          basic eps            -   \n",
       "13                                        diluted eps            -   \n",
       "14                               basic average shares            -   \n",
       "15                             diluted average shares            -   \n",
       "16                 total operating income as reported   99,938,000   \n",
       "17                                     total expenses  247,217,000   \n",
       "18  net income from continuing & discontinued oper...   86,802,000   \n",
       "19                                  normalized income   86,802,000   \n",
       "20                                    interest income    2,952,000   \n",
       "21                                   interest expense    2,607,000   \n",
       "22                                net interest income      345,000   \n",
       "23                                               ebit  103,467,000   \n",
       "24                                             ebitda  114,464,000   \n",
       "25                         reconciled cost of revenue  204,804,000   \n",
       "26                            reconciled depreciation   10,997,000   \n",
       "27  net income from continuing operation net minor...   86,802,000   \n",
       "28                                  normalized ebitda  114,464,000   \n",
       "29                                 tax rate for calcs            0   \n",
       "30                        tax effect of unusual items            0   \n",
       "31                                      total revenue    4,291,800   \n",
       "32                                    cost of revenue    2,749,200   \n",
       "33                                       gross profit    1,542,600   \n",
       "34                                       gross profit    1,542,600   \n",
       "35                                  operating expense      994,700   \n",
       "36                                   operating income      547,900   \n",
       "37          net non operating interest income expense     -144,200   \n",
       "38                               other income expense      -26,300   \n",
       "\n",
       "      9/29/2020    9/29/2019    9/29/2018    9/29/2017           finStat  \\\n",
       "0   274,515,000  260,174,000  265,595,000  229,234,000  income statement   \n",
       "1   169,559,000  161,782,000  163,756,000  141,048,000  income statement   \n",
       "2   104,956,000   98,392,000  101,839,000   88,186,000  income statement   \n",
       "3   104,956,000   98,392,000  101,839,000   88,186,000  income statement   \n",
       "4    38,668,000   34,462,000   30,941,000   26,842,000  income statement   \n",
       "5    66,288,000   63,930,000   70,898,000   61,344,000  income statement   \n",
       "6       890,000    1,385,000    2,446,000    2,878,000  income statement   \n",
       "7       -87,000      422,000     -441,000     -133,000  income statement   \n",
       "8    67,091,000   65,737,000   72,903,000   64,089,000  income statement   \n",
       "9     9,680,000   10,481,000   13,372,000   15,738,000  income statement   \n",
       "10   57,411,000   55,256,000   59,531,000   48,351,000  income statement   \n",
       "11   57,411,000   55,256,000   59,531,000   48,351,000  income statement   \n",
       "12         3.31         2.99         3.00         2.32  income statement   \n",
       "13         3.28         2.97         2.98         2.30  income statement   \n",
       "14   17,352,119   18,471,336   19,821,508   20,868,968  income statement   \n",
       "15   17,528,214   18,595,652   20,000,436   21,006,768  income statement   \n",
       "16   66,288,000   63,930,000   70,898,000   61,344,000  income statement   \n",
       "17  208,227,000  196,244,000  194,697,000  167,890,000  income statement   \n",
       "18   57,411,000   55,256,000   59,531,000   48,351,000  income statement   \n",
       "19   57,411,000   55,256,000   59,531,000   48,351,000  income statement   \n",
       "20    3,763,000    4,961,000    5,686,000    5,201,000  income statement   \n",
       "21    2,873,000    3,576,000    3,240,000    2,323,000  income statement   \n",
       "22      890,000    1,385,000    2,446,000    2,878,000  income statement   \n",
       "23   69,964,000   69,313,000   76,143,000   66,412,000  income statement   \n",
       "24            -            -            -            -  income statement   \n",
       "25  169,559,000  161,782,000  163,756,000  141,048,000  income statement   \n",
       "26   11,056,000   12,547,000   10,903,000   10,157,000  income statement   \n",
       "27   57,411,000   55,256,000   59,531,000   48,351,000  income statement   \n",
       "28   81,020,000   81,860,000   87,046,000   76,569,000  income statement   \n",
       "29            0            0            0            0  income statement   \n",
       "30            0            0            0            0  income statement   \n",
       "31          NaN          NaN          NaN          NaN  income statement   \n",
       "32          NaN          NaN          NaN          NaN  income statement   \n",
       "33          NaN          NaN          NaN          NaN  income statement   \n",
       "34          NaN          NaN          NaN          NaN  income statement   \n",
       "35          NaN          NaN          NaN          NaN  income statement   \n",
       "36          NaN          NaN          NaN          NaN  income statement   \n",
       "37          NaN          NaN          NaN          NaN  income statement   \n",
       "38          NaN          NaN          NaN          NaN  income statement   \n",
       "\n",
       "                     group_name           sector 12/30/2020 12/30/2019  \\\n",
       "0                         Apple       Technology        NaN        NaN   \n",
       "1                         Apple       Technology        NaN        NaN   \n",
       "2                         Apple       Technology        NaN        NaN   \n",
       "3                         Apple       Technology        NaN        NaN   \n",
       "4                         Apple       Technology        NaN        NaN   \n",
       "5                         Apple       Technology        NaN        NaN   \n",
       "6                         Apple       Technology        NaN        NaN   \n",
       "7                         Apple       Technology        NaN        NaN   \n",
       "8                         Apple       Technology        NaN        NaN   \n",
       "9                         Apple       Technology        NaN        NaN   \n",
       "10                        Apple       Technology        NaN        NaN   \n",
       "11                        Apple       Technology        NaN        NaN   \n",
       "12                        Apple       Technology        NaN        NaN   \n",
       "13                        Apple       Technology        NaN        NaN   \n",
       "14                        Apple       Technology        NaN        NaN   \n",
       "15                        Apple       Technology        NaN        NaN   \n",
       "16                        Apple       Technology        NaN        NaN   \n",
       "17                        Apple       Technology        NaN        NaN   \n",
       "18                        Apple       Technology        NaN        NaN   \n",
       "19                        Apple       Technology        NaN        NaN   \n",
       "20                        Apple       Technology        NaN        NaN   \n",
       "21                        Apple       Technology        NaN        NaN   \n",
       "22                        Apple       Technology        NaN        NaN   \n",
       "23                        Apple       Technology        NaN        NaN   \n",
       "24                        Apple       Technology        NaN        NaN   \n",
       "25                        Apple       Technology        NaN        NaN   \n",
       "26                        Apple       Technology        NaN        NaN   \n",
       "27                        Apple       Technology        NaN        NaN   \n",
       "28                        Apple       Technology        NaN        NaN   \n",
       "29                        Apple       Technology        NaN        NaN   \n",
       "30                        Apple       Technology        NaN        NaN   \n",
       "31  Axalta Coating Systems Ltd.  Basic Materials  3,737,600  4,482,200   \n",
       "32  Axalta Coating Systems Ltd.  Basic Materials  2,457,900  2,917,900   \n",
       "33  Axalta Coating Systems Ltd.  Basic Materials  1,279,700  1,564,300   \n",
       "34  Axalta Coating Systems Ltd.  Basic Materials  1,279,700  1,564,300   \n",
       "35  Axalta Coating Systems Ltd.  Basic Materials    974,200  1,076,100   \n",
       "36  Axalta Coating Systems Ltd.  Basic Materials    305,500    488,200   \n",
       "37  Axalta Coating Systems Ltd.  Basic Materials   -149,900   -162,600   \n",
       "38  Axalta Coating Systems Ltd.  Basic Materials    -33,400      4,400   \n",
       "\n",
       "   12/30/2018 12/30/2017                             IFRS_tag  \n",
       "0         NaN        NaN         ifrs-full_Revenue_totalLabel  \n",
       "1         NaN        NaN                                  NaN  \n",
       "2         NaN        NaN          ifrs-full_GrossProfit_label  \n",
       "3         NaN        NaN       ifrs-full_GrossProfit_netLabel  \n",
       "4         NaN        NaN     ifrs-full_OperatingExpense_label  \n",
       "5         NaN        NaN                                  NaN  \n",
       "6         NaN        NaN                                  NaN  \n",
       "7         NaN        NaN                                  NaN  \n",
       "8         NaN        NaN                                  NaN  \n",
       "9         NaN        NaN                                  NaN  \n",
       "10        NaN        NaN                                  NaN  \n",
       "11        NaN        NaN                                  NaN  \n",
       "12        NaN        NaN                                  NaN  \n",
       "13        NaN        NaN                                  NaN  \n",
       "14        NaN        NaN                                  NaN  \n",
       "15        NaN        NaN                                  NaN  \n",
       "16        NaN        NaN                                  NaN  \n",
       "17        NaN        NaN                                  NaN  \n",
       "18        NaN        NaN                                  NaN  \n",
       "19        NaN        NaN                                  NaN  \n",
       "20        NaN        NaN  ifrs-full_RevenueFromInterest_label  \n",
       "21        NaN        NaN      ifrs-full_InterestExpense_label  \n",
       "22        NaN        NaN                                  NaN  \n",
       "23        NaN        NaN                                  NaN  \n",
       "24        NaN        NaN                                  NaN  \n",
       "25        NaN        NaN                                  NaN  \n",
       "26        NaN        NaN                                  NaN  \n",
       "27        NaN        NaN                                  NaN  \n",
       "28        NaN        NaN                                  NaN  \n",
       "29        NaN        NaN                                  NaN  \n",
       "30        NaN        NaN                                  NaN  \n",
       "31  4,696,000  4,377,000         ifrs-full_Revenue_totalLabel  \n",
       "32  3,106,300  2,779,600                                  NaN  \n",
       "33  1,589,700  1,597,400          ifrs-full_GrossProfit_label  \n",
       "34  1,589,700  1,597,400       ifrs-full_GrossProfit_netLabel  \n",
       "35  1,147,600  1,164,200     ifrs-full_OperatingExpense_label  \n",
       "36    442,100    433,200                                  NaN  \n",
       "37   -159,600   -147,000                                  NaN  \n",
       "38    -15,000    -96,600                                  NaN  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df=pd.merge(dfs, df_tag,on='elt',how='left')\n",
    "print(len(df))\n",
    "print(len(dfs))\n",
    "df.head(39)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['gross profit',\n",
       " 'operating expense',\n",
       " 'interest income',\n",
       " 'interest expense',\n",
       " 'total revenue']"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#FIND INTERSECTION OF 2 LISTS\n",
    "L1=list(dfs['elt'].unique())\n",
    "L2=list(df_tag['elt'])\n",
    "list(set(L1) & set(L2))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "34"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(L1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "5876"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(L2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['accounting profit',\n",
       " 'accumulated increase (decrease) in fair value of financial liability, attributable to changes in credit risk of liability',\n",
       " 'accumulated increase (decrease) in fair value of loan or receivable, attributable to changes in credit risk of financial assets',\n",
       " 'acquisitions through business combinations, biological assets',\n",
       " 'acquisitions through business combinations, intangible assets other than goodwill',\n",
       " 'acquisitions through business combinations, investment property',\n",
       " 'acquisitions through business combinations, other provisions',\n",
       " 'acquisitions through business combinations, property, plant and equipment',\n",
       " 'actuarial assumption of discount rates',\n",
       " 'actuarial assumption of expected rates of salary increases',\n",
       " 'actuarial assumption of medical cost trend rates',\n",
       " 'additional information about entity exposure to risk',\n",
       " 'additional information [abstract]',\n",
       " 'additional provisions, other provisions',\n",
       " 'additional recognition, goodwill',\n",
       " 'additions from acquisitions, investment property',\n",
       " 'additions from subsequent expenditure recognised as asset, investment property',\n",
       " 'additions, investment property [abstract]',\n",
       " 'additions other than through business combinations, biological assets',\n",
       " 'additions other than through business combinations, intangible assets other than goodwill',\n",
       " 'additions other than through business combinations, investment property',\n",
       " 'additions other than through business combinations, property, plant and equipment',\n",
       " \"address of entity's registered office\",\n",
       " 'amounts removed from equity and included in carrying amount of non-financial asset (liability) whose acquisition or incurrence was hedged highly probable forecast transaction, net of tax',\n",
       " 'adjustments for decrease (increase) in inventories',\n",
       " 'adjustments for decrease (increase) in other operating receivables',\n",
       " 'adjustments for decrease (increase) in trade accounts receivable',\n",
       " 'adjustments for increase (decrease) in other operating payables',\n",
       " 'adjustments for increase (decrease) in trade accounts payable',\n",
       " 'adjustments for losses (gains) on disposal of non-current assets',\n",
       " 'adjustments for provisions',\n",
       " 'adjustments to reconcile profit (loss)',\n",
       " 'adjustments to reconcile profit (loss) [abstract]',\n",
       " 'adjustments for undistributed profits of associates',\n",
       " 'adjustments for unrealised foreign exchange losses (gains)',\n",
       " 'administrative expenses',\n",
       " 'current and deferred tax relating to items credited (charged) directly to equity',\n",
       " 'current and deferred tax relating to items charged or credited directly to equity [abstract]',\n",
       " 'current tax relating to items credited (charged) directly to equity',\n",
       " 'allowance account for credit losses of financial assets',\n",
       " 'amortisation, intangible assets other than goodwill',\n",
       " 'amortisation method, intangible assets other than goodwill',\n",
       " 'analysis of age of financial assets that are past due but not impaired [text block]',\n",
       " 'analysis of financial assets that are individually determined to be impaired [text block]',\n",
       " 'analysis of income and expense [abstract]',\n",
       " 'applicable tax rate',\n",
       " 'assets',\n",
       " 'assets [abstract]',\n",
       " 'available-for-sale financial assets [abstract]',\n",
       " 'average effective tax rate',\n",
       " 'balances with banks',\n",
       " 'other banking arrangements, classified as cash equivalents',\n",
       " 'bank overdrafts',\n",
       " 'basic earnings (loss) per share',\n",
       " 'basic earnings (loss) per share from continuing operations',\n",
       " 'basic earnings (loss) per share from discontinued operations',\n",
       " 'basic earnings per share [abstract]',\n",
       " 'description of basis for attributing revenues from external customers to individual countries',\n",
       " 'biological assets',\n",
       " 'biological assets [member]',\n",
       " 'borrowing costs capitalised',\n",
       " 'brand names',\n",
       " 'brand names [member]',\n",
       " 'capitalisation rate of borrowing costs eligible for capitalisation',\n",
       " 'cash advances and loans made to other parties, classified as investing activities',\n",
       " 'cash and cash equivalents',\n",
       " 'cash and cash equivalents [abstract]',\n",
       " 'cash flow hedges [abstract]',\n",
       " 'cash flows from continuing and discontinued operations [abstract]',\n",
       " 'cash flows from losing control of subsidiaries or other businesses, classified as investing activities',\n",
       " 'cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities',\n",
       " 'cash flows from (used in) financing activities',\n",
       " 'cash flows from (used in) financing activities [abstract]',\n",
       " 'cash flows from (used in) financing activities, continuing operations',\n",
       " 'cash flows from (used in) financing activities, discontinued operations',\n",
       " 'cash flows from (used in) investing activities',\n",
       " 'cash flows from (used in) investing activities [abstract]',\n",
       " 'cash flows from (used in) investing activities, continuing operations',\n",
       " 'cash flows from (used in) investing activities, discontinued operations',\n",
       " 'cash flows from (used in) operating activities',\n",
       " 'cash flows from (used in) operating activities [abstract]',\n",
       " 'cash flows from (used in) operating activities, continuing operations',\n",
       " 'cash flows from (used in) operating activities, discontinued operations',\n",
       " 'cash on hand',\n",
       " 'cash receipts from repayment of advances and loans made to other parties, classified as investing activities',\n",
       " 'increase (decrease) in amount recognised for pre-acquisition deferred tax asset',\n",
       " 'increase (decrease) in biological assets',\n",
       " 'changes in biological assets [abstract]',\n",
       " 'increase (decrease) in equity',\n",
       " 'changes in equity [abstract]',\n",
       " 'description of changes in exposure to risk',\n",
       " 'increase (decrease) in fair value of financial liability, attributable to changes in credit risk of liability',\n",
       " 'increase (decrease) in fair value of loans or receivables, attributable to changes in credit risk of financial assets',\n",
       " 'increase (decrease) in goodwill',\n",
       " 'changes in goodwill [abstract]',\n",
       " 'increase (decrease) in intangible assets other than goodwill',\n",
       " 'changes in intangible assets other than goodwill [abstract]',\n",
       " 'decrease (increase) in inventories of finished goods and work in progress',\n",
       " 'increase (decrease) in investment property',\n",
       " 'changes in investment property [abstract]',\n",
       " 'description of changes in methods and assumptions used in preparing sensitivity analysis',\n",
       " 'description of changes in methods used to measure risk',\n",
       " 'description of changes in objectives, policies and processes for managing risk',\n",
       " 'increase (decrease) in other provisions',\n",
       " 'changes in other provisions [abstract]',\n",
       " 'increase (decrease) in property, plant and equipment',\n",
       " 'changes in property, plant and equipment [abstract]',\n",
       " 'description of circumstances leading to reversals of inventory write-down',\n",
       " 'classes of cash receipts from operating activities [abstract]',\n",
       " 'classes of employee benefits expense [abstract]',\n",
       " 'classes of other provisions [abstract]',\n",
       " 'comprehensive income',\n",
       " 'comprehensive income [abstract]',\n",
       " 'comprehensive income attributable to [abstract]',\n",
       " 'comprehensive income, attributable to non-controlling interests',\n",
       " 'comprehensive income, attributable to owners of parent',\n",
       " 'computer software',\n",
       " 'computer software [member]',\n",
       " 'description of concentrations of risk',\n",
       " 'construction in progress',\n",
       " 'construction in progress [member]',\n",
       " 'copyrights, patents and other industrial property rights, service and operating rights',\n",
       " 'copyrights, patents and other industrial property rights, service and operating rights [member]',\n",
       " 'cost of inventories recognised as expense during period',\n",
       " 'cost of sales',\n",
       " 'country of incorporation',\n",
       " 'cumulative change in fair value recognised in profit or loss on sales of investment property between pools of assets measured using different models',\n",
       " 'cumulative unrecognised share of losses of associates',\n",
       " 'current assets',\n",
       " 'current assets [abstract]',\n",
       " 'current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners',\n",
       " 'current liabilities',\n",
       " 'current liabilities [abstract]',\n",
       " 'current liabilities other than liabilities included in disposal groups classified as held for sale',\n",
       " 'current provisions for employee benefits',\n",
       " 'current tax assets',\n",
       " 'current tax expense (income)',\n",
       " 'current tax liabilities',\n",
       " 'decrease due to harvest, biological assets',\n",
       " 'decrease through classified as held for sale, biological assets',\n",
       " 'decrease through classified as held for sale, goodwill',\n",
       " 'decrease through classified as held for sale, intangible assets other than goodwill',\n",
       " 'decrease through classified as held for sale, investment property',\n",
       " 'decrease through classified as held for sale, property, plant and equipment',\n",
       " 'deductible temporary differences for which no deferred tax asset is recognised',\n",
       " 'deferred tax assets',\n",
       " 'deferred tax assets and liabilities [abstract]',\n",
       " 'deferred tax expense arising from write-down or reversal of write-down of deferred tax asset',\n",
       " 'deferred tax expense (income)',\n",
       " 'deferred tax expense (income) [abstract]',\n",
       " 'deferred tax expense (income) relating to origination and reversal of temporary differences',\n",
       " 'deferred tax expense (income) relating to tax rate changes or imposition of new taxes',\n",
       " 'deferred tax liabilities',\n",
       " 'deferred tax liability (asset)',\n",
       " 'deferred tax relating to items credited (charged) directly to equity',\n",
       " 'defined benefit obligation, at present value',\n",
       " 'depreciation and amortisation expense',\n",
       " 'depreciation, biological assets',\n",
       " 'depreciation, investment property',\n",
       " 'depreciation method, biological assets, at cost',\n",
       " 'depreciation method, investment property, cost model',\n",
       " 'depreciation method, property, plant and equipment',\n",
       " 'depreciation, property, plant and equipment',\n",
       " 'description of accounting policy for exploration and evaluation expenditures [text block]',\n",
       " 'description of accounting policy for government grants [text block]',\n",
       " 'description of accounting policy for insurance contracts and related assets, liabilities, income and expense [text block]',\n",
       " 'description of accounting policy for measuring inventories [text block]',\n",
       " 'description of accounting policy for recognition of revenue [text block]',\n",
       " 'description of acquisition of entity by means of equity issue',\n",
       " 'description of biological assets',\n",
       " 'description of biological assets previously measured at cost',\n",
       " 'description of biological assets where fair value information is unreliable',\n",
       " 'description of changes in plan to sell non-current asset or disposal group held for sale',\n",
       " 'description of collateral held as security and other credit enhancements and their financial effect in respect of amount that best represents maximum exposure',\n",
       " \"description of terms and conditions associated with entity's use of collateral permitted to be sold or repledged in absence of default by owner of collateral\",\n",
       " 'description of compliance with ifrss if applied for interim financial report',\n",
       " 'description of conversion of debt to equity',\n",
       " 'description of details of defaults during period of principal, interest, sinking fund, or redemption terms of loans payable',\n",
       " 'description of event or change in circumstances that caused recognition of deferred tax benefits acquired in business combination after acquisition date',\n",
       " 'description of exposure to risk',\n",
       " 'fair value of investments in associates for which there are quoted market prices',\n",
       " 'fair value of property, plant and equipment materially different from carrying amount',\n",
       " 'financial assets pledged as collateral for liabilities or contingent liabilities',\n",
       " 'description of financial instruments designated as hedging instruments',\n",
       " 'description of financial risk management related to agricultural activity',\n",
       " 'description of fully amortised intangible assets',\n",
       " 'description of functional currency',\n",
       " 'description of investment property where fair value information is unreliable, cost model',\n",
       " 'key management personnel compensation',\n",
       " 'key management personnel compensation, post-employment benefits',\n",
       " 'key management personnel compensation, share-based payment',\n",
       " 'key management personnel compensation, short-term employee benefits',\n",
       " 'key management personnel compensation, termination benefits',\n",
       " 'disclosure of how entity manages liquidity risk [text block]',\n",
       " 'description of nature of accounting errors in prior periods [text block]',\n",
       " 'description of nature and amount of change in estimate during final interim period',\n",
       " 'description of nature of assets obtained by taking possession of collateral or calling on other credit enhancements',\n",
       " 'description of nature and extent of government grants for agricultural activity recognised in financial statements',\n",
       " 'description of nature and extent of government grants recognised in financial statements',\n",
       " 'description of nature and financial effect of business combinations after reporting period before statements authorised for issue',\n",
       " 'description of nature and financial effect of business combinations during period',\n",
       " 'description of nature and purpose of reserves within equity',\n",
       " 'description of nature of activities of biological assets',\n",
       " 'description of nature of contingent assets',\n",
       " \"description of nature of entity's operations and principal activities\",\n",
       " 'description of nature of financial statements',\n",
       " 'description of nature of interest in funds',\n",
       " 'description of nature of necessary adjustments to provide comparative information',\n",
       " 'description of nature of non-adjusting event after reporting period',\n",
       " 'description of nature of reclassifications or changes in presentation',\n",
       " 'description of nature of risks being hedged',\n",
       " 'description of non-current asset or disposal group held for sale which were sold or reclassified',\n",
       " 'description of objectives, policies and processes for managing risk',\n",
       " 'description of other accounting policies relevant to understanding of financial statements [text block]',\n",
       " 'description of periods when cash flows affect profit or loss',\n",
       " 'description of periods when cash flows expected to occur',\n",
       " 'description of policies for disposal or for use in operation of assets obtained by taking possession of collateral or other credit enhancement [text block]',\n",
       " 'description of presentation currency',\n",
       " 'description of reason for change in functional currency',\n",
       " 'description of reason for reclassifications or changes in presentation',\n",
       " 'description of reason for using longer or shorter reporting period',\n",
       " 'description of reasons why presumption investor does not have significant influence is overcome when its interest in investee is less than twenty per cent',\n",
       " 'description of reasons why presumption investor has significant influence is overcome when its interest in investee is more than twenty per cent',\n",
       " 'description of reason why fair value of goods or services received cannot be reliably estimated',\n",
       " 'description of fact that amounts presented in financial statements are not entirely comparable',\n",
       " 'description of reason why presentation currency is different from functional currency',\n",
       " 'description of reason why reclassification of comparative amounts is impracticable',\n",
       " 'description of reason why using different reporting date or period for associate',\n",
       " 'description of redesignated financial assets',\n",
       " 'description of redesignated financial liabilities',\n",
       " 'share of contingent liabilities of associates incurred jointly with other investors',\n",
       " 'description of significant intangible assets controlled by entity but not recognised',\n",
       " 'description of transactions after reporting period that significantly change number of ordinary shares outstanding',\n",
       " 'description of transactions after reporting period that significantly change number of potential ordinary shares outstanding',\n",
       " 'description of type of hedge',\n",
       " 'description of type of plan',\n",
       " 'description of types of products and services from which each reportable segment derives its revenues',\n",
       " 'description of unfulfilled conditions and other contingencies attached to government grant for agricultural activity',\n",
       " 'designated financial liabilities at fair value through profit or loss [abstract]',\n",
       " 'designated loans or receivables at fair value through profit or loss [abstract]',\n",
       " 'explanation of determination of fair value of goods or services received or fair value of equity instruments granted on share-based payments',\n",
       " 'difference between carrying amount of financial liability and amount contractually required to pay at maturity to holder of obligation',\n",
       " 'diluted earnings (loss) per share',\n",
       " 'diluted earnings (loss) per share from continuing operations',\n",
       " 'diluted earnings (loss) per share from discontinued operations',\n",
       " 'diluted earnings per share [abstract]',\n",
       " 'direct operating expense from investment property generating rental income',\n",
       " 'disclosure of additional information about understanding financial position and liquidity of entity [text block]',\n",
       " 'disclosure of amounts arising from insurance contracts [text block]',\n",
       " 'disclosure of biological assets, agriculture produce at point of harvest and government grants related to biological assets [text block]',\n",
       " 'disclosure of borrowing costs [text block]',\n",
       " 'disclosure of business combinations [text block]',\n",
       " 'disclosure of cash flow statement [text block]',\n",
       " 'disclosure of changes in accounting policies, accounting estimates and errors [text block]',\n",
       " 'disclosure of classes of share capital [text block]',\n",
       " 'disclosure of comparative information prepared under previous gaap [text block]',\n",
       " 'description of compound financial instruments with multiple embedded derivatives',\n",
       " 'disclosure of contingent liabilities [text block]',\n",
       " 'disclosure of defined benefit plans [text block]',\n",
       " 'disclosure of earnings per share [text block]',\n",
       " 'disclosure of effect of changes in foreign exchange rates [text block]',\n",
       " \"disclosure of entity's operating segments [text block]\",\n",
       " 'disclosure of events after reporting period [text block]',\n",
       " 'disclosure of exploration and evaluation assets [text block]',\n",
       " 'disclosure of information about possible differences between carrying amount and fair value of contracts described in ifrs 7.29 b and ifrs 7.29 c [text block]',\n",
       " 'disclosure of fair values of items used as deemed cost [text block]',\n",
       " 'disclosure of financial assets that are either past due or impaired [text block]',\n",
       " 'disclosure of transferred financial assets that are not derecognised in their entirety [text block]',\n",
       " 'disclosure of general information about financial statements [text block]',\n",
       " 'explanation of goodwill not allocated to cash-generating unit',\n",
       " 'disclosure of government grants [text block]',\n",
       " 'disclosure of hedge accounting [text block]',\n",
       " 'disclosure of hyperinflationary reporting [text block]',\n",
       " 'disclosure of impairment loss and reversal of impairment loss [text block]',\n",
       " 'disclosure of income tax [text block]',\n",
       " 'description of instruments with potential future dilutive effect not included in calculation of diluted earnings per share',\n",
       " 'disclosure of insurance contracts [text block]',\n",
       " 'disclosure of intangible assets [text block]',\n",
       " 'disclosure of interest in funds [text block]',\n",
       " 'disclosure of interim financial reporting [text block]',\n",
       " 'disclosure of inventories [text block]',\n",
       " 'disclosure of nature and extent of risks arising from insurance contracts [text block]',\n",
       " 'description of nature of potential income tax consequences that would result from payment of dividend',\n",
       " 'disclosure of non-adjusting events after reporting period [text block]',\n",
       " 'disclosure of notes and other explanatory information [text block]',\n",
       " 'disclosure of number and weighted average exercise prices of share options [text block]',\n",
       " 'disclosure of objectives, policies and processes for managing capital [text block]',\n",
       " 'disclosure of other provisions, contingent liabilities and contingent assets [text block]',\n",
       " 'disclosure of property, plant and equipment [text block]',\n",
       " 'description of evidence supporting recognition of deferred tax asset when utilisation is dependent on future taxable profits in excess of profits from reversal of taxable temporary differences and entity has suffered loss in jurisdiction to which deferred tax asset relates',\n",
       " 'disclosure of redemption prohibition, transfer between financial liabilities and equity [text block]',\n",
       " 'disclosure of redesignated financial assets and liabilities [text block]',\n",
       " 'disclosure of related party [text block]',\n",
       " 'disclosure of reserves within equity [text block]',\n",
       " 'disclosure of revenue [text block]',\n",
       " 'disclosure of major customers [text block]',\n",
       " 'disclosure of share-based payment arrangements [text block]',\n",
       " 'disclosure of share capital, reserves and other equity interest [text block]',\n",
       " 'disclosure of significant adjustments to valuation obtained [text block]',\n",
       " 'cash and cash equivalents held by entity unavailable for use by group',\n",
       " 'disclosure of transactions between related parties [text block]',\n",
       " 'explanation of whether default was remedied or terms of loans payable were renegotiated before financial statements were authorised for issue',\n",
       " 'disposals, biological assets',\n",
       " 'disposals, intangible assets other than goodwill',\n",
       " 'disposals, investment property',\n",
       " 'disposals, property, plant and equipment',\n",
       " 'distribution costs',\n",
       " 'dividends recognised as distributions to owners',\n",
       " 'dividends paid, classified as financing activities',\n",
       " 'dividends paid, classified as operating activities',\n",
       " 'dividends received, classified as investing activities',\n",
       " 'dividends received, classified as operating activities',\n",
       " 'domicile of entity',\n",
       " 'earnings per share [abstract]',\n",
       " 'effective dates of revaluation, intangible assets other than goodwill',\n",
       " 'effective dates of revaluation, property, plant and equipment',\n",
       " 'effect of exchange rate changes on cash and cash equivalents',\n",
       " 'effect of exchange rate changes on cash and cash equivalents [abstract]',\n",
       " 'employee benefits expense',\n",
       " 'equity',\n",
       " 'equity [abstract]',\n",
       " 'equity and liabilities',\n",
       " 'equity and liabilities [abstract]',\n",
       " 'equity attributable to owners of parent',\n",
       " 'exchange differences on translation [abstract]',\n",
       " 'expenses, by nature',\n",
       " 'expenses by nature [abstract]',\n",
       " 'expense of restructuring activities',\n",
       " 'commitments for development or acquisition of biological assets',\n",
       " 'explanation of assets acquired by way of government grant and initially recognised at fair value',\n",
       " 'explanation of sources of estimation uncertainty with significant risk of causing material adjustment',\n",
       " 'explanation of process used to determine assumptions to measure recognised assets, liabilities, income and expense arising from insurance contracts',\n",
       " 'explanation of body of authorisation',\n",
       " 'explanation of change in name of reporting entity or other means of identification from end of preceding reporting period',\n",
       " 'explanation of changes in applicable tax rates to previous accounting period',\n",
       " 'contractual commitments for acquisition of intangible assets',\n",
       " 'contractual commitments for acquisition of property, plant and equipment',\n",
       " 'explanation of contractual obligations to purchase, construct or develop investment property or for repairs, maintenance or enhancements',\n",
       " 'cumulative preference dividends not recognised',\n",
       " 'explanation of departure from ifrs',\n",
       " 'explanation of direct measurement of fair value of goods or services received',\n",
       " 'dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners',\n",
       " 'explanation of effect of change for biological asset for which fair value becomes reliably measurable',\n",
       " 'explanation of effect of changes in assumptions to measure insurance assets and insurance liabilities',\n",
       " 'explanation of effect of changes in plan to sell non-current asset or disposal group held for sale on results of operations for current period',\n",
       " 'explanation of effect of changes in plan to sell non-current asset or disposal group held for sale on results of operations for prior period',\n",
       " 'explanation of effect of transition on reported cash flows',\n",
       " 'explanation of effect of transition on reported financial performance',\n",
       " 'explanation of effect of transition on reported financial position',\n",
       " 'explanation of estimated financial effect of contingent assets',\n",
       " 'explanation of facts and circumstances of sale or reclassification and expected disposal, manner and timing',\n",
       " 'explanation of financial effect of adjustments related to business combinations',\n",
       " 'explanation of financial effect of departure from ifrs',\n",
       " 'description of line item(s) in profit or loss in which gain (loss) is recognised when control of subsidiary is lost',\n",
       " 'explanation of interest income reported net of interest expense',\n",
       " 'inventories pledged as security for liabilities',\n",
       " 'explanation of investing and financing transactions not requiring use of cash or cash equivalents',\n",
       " \"explanation of management judgements in applying entity's accounting policies with significant effect on recognised amounts\",\n",
       " 'explanation of why revenues from external customers for each product and service, or each group of similar products and services, are not reported',\n",
       " 'explanation of new standards or interpretations not applied',\n",
       " \"explanation of fact that entity's owners or others have power to amend financial statements after issue\",\n",
       " 'property, plant and equipment, pledged as security',\n",
       " 'explanation of relationships between parent and subsidiaries',\n",
       " 'explanation of restrictions on distribution of revaluation surplus for intangible assets',\n",
       " 'explanation of significant decrease in level of government grants for agricultural activity',\n",
       " 'consideration paid (received)',\n",
       " 'explanation of unfulfilled conditions and other contingencies attaching to government assistance',\n",
       " 'explanation of why fair value becomes reliable for biological assets previously measured at cost',\n",
       " 'explanation of why fair value cannot be reliably measured for biological assets, at cost',\n",
       " 'explanation of why fair value cannot be reliably measured for investment property, cost model',\n",
       " 'explanation of why entity not regarded as going concern',\n",
       " \"description of factors used to identify entity's reportable segments\",\n",
       " 'fee income and expense [abstract]',\n",
       " 'fee income (expense) arising from financial assets or financial liabilities not at fair value through profit or loss',\n",
       " 'fee income (expense) arising from trust and fiduciary activities',\n",
       " 'finance costs',\n",
       " 'financial assets available-for-sale',\n",
       " 'financial instruments designated as hedging instruments, at fair value',\n",
       " 'financial liabilities at amortised cost',\n",
       " 'financial liabilities at fair value through profit or loss',\n",
       " 'disclosure of fair values of items used as deemed cost [abstract]',\n",
       " 'disclosure of redesignated financial assets and liabilities [abstract]',\n",
       " 'fixtures and fittings',\n",
       " 'fixtures and fittings [member]',\n",
       " 'gains (losses) on available-for-sale financial assets',\n",
       " 'gains (losses) on cash flow hedges, before tax',\n",
       " 'gains (losses) on cash flow hedges, net of tax',\n",
       " 'gains (losses) on disposals of investments',\n",
       " 'gains (losses) on disposals of other non-current assets',\n",
       " 'gains (losses) on disposals of property, plant and equipment',\n",
       " 'foreign exchange gain (loss)',\n",
       " 'gains (losses) on fair value adjustment, biological assets',\n",
       " 'gains (losses) on fair value adjustment, investment property',\n",
       " 'gains (losses) on financial instruments [abstract]',\n",
       " 'gains (losses) on financial liabilities at amortised cost',\n",
       " 'gains (losses) on hedged item attributable to hedged risk, fair value hedges',\n",
       " 'gains (losses) on hedging instrument, fair value hedges',\n",
       " 'gains (losses) on held-to-maturity investments',\n",
       " 'gains (losses) on ineffectiveness of cash flow hedges recognised in profit or loss',\n",
       " 'gains (losses) on litigation settlements',\n",
       " 'gains (losses) on loans and receivables',\n",
       " 'gains (losses) on net monetary position',\n",
       " 'gains (losses) on remeasuring available-for-sale financial assets, before tax',\n",
       " 'gains (losses) on remeasuring available-for-sale financial assets, net of tax',\n",
       " 'gains (losses) recognised when control of subsidiary is lost',\n",
       " 'goodwill',\n",
       " 'gross profit',\n",
       " 'description of identity of price index',\n",
       " 'disclosure of impairment loss and reversal of impairment loss [abstract]',\n",
       " 'impairment loss recognised in other comprehensive income',\n",
       " 'impairment loss recognised in other comprehensive income, intangible assets other than goodwill',\n",
       " 'impairment loss recognised in other comprehensive income, property, plant and equipment',\n",
       " 'impairment loss recognised in profit or loss',\n",
       " 'impairment loss recognised in profit or loss, biological assets',\n",
       " 'impairment loss recognised in profit or loss, goodwill',\n",
       " 'impairment loss recognised in profit or loss, intangible assets other than goodwill',\n",
       " 'impairment loss recognised in profit or loss, investment property',\n",
       " 'impairment loss recognised in profit or loss, property, plant and equipment',\n",
       " 'impairment loss on financial assets',\n",
       " 'impairment loss (reversal of impairment loss) recognised in profit or loss',\n",
       " 'reversal of impairment loss recognised in other comprehensive income',\n",
       " 'reversal of impairment loss recognised in other comprehensive income, intangible assets other than goodwill',\n",
       " 'reversal of impairment loss recognised in other comprehensive income, property, plant and equipment',\n",
       " 'reversal of impairment loss recognised in profit or loss',\n",
       " 'reversal of impairment loss recognised in profit or loss, biological assets',\n",
       " 'reversal of impairment loss recognised in profit or loss, intangible assets other than goodwill',\n",
       " 'reversal of impairment loss recognised in profit or loss, investment property',\n",
       " 'reversal of impairment loss recognised in profit or loss, property, plant and equipment',\n",
       " 'income, expense, gains or losses of financial instruments [abstract]',\n",
       " 'income tax consequences of dividends proposed or declared before financial statements authorised for issue not recognised as liability',\n",
       " 'income taxes paid (refund), classified as financing activities',\n",
       " 'income taxes paid (refund), classified as investing activities',\n",
       " 'income taxes paid (refund), classified as operating activities',\n",
       " 'income tax relating to components of other comprehensive income',\n",
       " 'income tax relating to components of other comprehensive income [abstract]',\n",
       " 'income tax relating to share of other comprehensive income of associates and joint ventures accounted for using equity method',\n",
       " 'increase (decrease) in allowance account for credit losses of financial assets',\n",
       " 'increase (decrease) through change in discount rate, other provisions',\n",
       " 'increase (decrease) through net exchange differences, biological assets',\n",
       " 'increase (decrease) through net exchange differences, goodwill',\n",
       " 'increase (decrease) through net exchange differences, intangible assets other than goodwill',\n",
       " 'increase (decrease) through net exchange differences, investment property',\n",
       " 'increase (decrease) through net exchange differences, other provisions',\n",
       " 'increase (decrease) through net exchange differences, property, plant and equipment',\n",
       " 'increase through adjustments arising from passage of time, other provisions',\n",
       " 'increase (decrease) through other changes, biological assets',\n",
       " 'increase (decrease) through other changes, goodwill',\n",
       " 'increase (decrease) through transfers and other changes, intangible assets other than goodwill',\n",
       " 'increase (decrease) through transfers and other changes, other provisions',\n",
       " 'increase (decrease) through transfers and other changes, property, plant and equipment',\n",
       " 'indication of other forms of government assistance with direct benefits for entity',\n",
       " 'information about contingent assets that disclosure is not practicable',\n",
       " 'information about contingent liabilities that disclosure is not practicable',\n",
       " 'information about credit quality of neither past due nor impaired financial assets [text block]',\n",
       " 'information about major customers',\n",
       " 'intangible assets other than goodwill',\n",
       " 'intangible assets other than goodwill [abstract]',\n",
       " 'intangible assets other than goodwill, revaluation surplus',\n",
       " 'intangible assets under development',\n",
       " 'intangible assets under development [member]',\n",
       " 'intangible exploration and evaluation assets',\n",
       " 'intangible exploration and evaluation assets [member]',\n",
       " 'interest expense',\n",
       " 'interest expense for financial liabilities not at fair value through profit or loss',\n",
       " 'interest income and interest expense for financial assets or financial liabilities not at fair value through profit or loss [abstract]',\n",
       " 'interest income for financial assets not at fair value through profit or loss',\n",
       " 'interest income on impaired financial assets accrued',\n",
       " 'interest income on impaired financial assets accrued [abstract]',\n",
       " 'interest paid, classified as financing activities',\n",
       " 'interest paid, classified as operating activities',\n",
       " 'interest received, classified as investing activities',\n",
       " 'interest received, classified as operating activities',\n",
       " 'interest income (expense)',\n",
       " \"intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested\",\n",
       " 'current inventories',\n",
       " 'inventories, at fair value less costs to sell',\n",
       " 'description of inventory cost formulas',\n",
       " 'inventory write-down',\n",
       " 'investments accounted for using equity method',\n",
       " 'investment property',\n",
       " 'issued capital',\n",
       " 'issue of equity',\n",
       " 'land and buildings',\n",
       " 'land and buildings [member]',\n",
       " 'legal form of entity',\n",
       " 'legal proceedings provision',\n",
       " 'legal proceedings provision [abstract]',\n",
       " 'level of price index',\n",
       " 'level of rounding used in financial statements',\n",
       " 'liabilities',\n",
       " 'liabilities [abstract]',\n",
       " 'liabilities from share-based payment transactions',\n",
       " 'liabilities included in disposal groups classified as held for sale',\n",
       " 'licences and franchises',\n",
       " 'licences and franchises [member]',\n",
       " 'description of objective of method used and limitations that may result in information not fully reflecting fair value of assets and liabilities involved',\n",
       " 'description of line item(s) in statement of comprehensive income in which amortisation of intangible assets is included',\n",
       " 'loans payable in default',\n",
       " 'non-current legal proceedings provision',\n",
       " 'non-current miscellaneous other provisions',\n",
       " 'non-current onerous contracts provision',\n",
       " 'non-current provision for decommissioning, restoration and rehabilitation costs',\n",
       " 'non-current restructuring provision',\n",
       " 'non-current warranty provision',\n",
       " 'machinery',\n",
       " 'machinery [member]',\n",
       " 'major components of tax expense (income) [abstract]',\n",
       " 'management conclusion on fair presentation as consequence of departure',\n",
       " 'mastheads and publishing titles',\n",
       " 'mastheads and publishing titles [member]',\n",
       " 'material income and expense [abstract]',\n",
       " 'disclosure of maturity analysis for non-derivative financial liabilities [text block]',\n",
       " 'maximum exposure to credit risk',\n",
       " 'maximum exposure to credit risk of loans or receivables',\n",
       " 'measurement bases, property, plant and equipment',\n",
       " 'description of methods and assumptions used in preparing sensitivity analysis',\n",
       " 'description of methods of translation used to determine supplementary information',\n",
       " 'description of methods to determine amount of changes in fair value of financial assets and financial liabilities attributable to changes in credit risk',\n",
       " 'description of method, parameters and assumptions used in preparing sensitivity analysis reflecting interdependencies between risk variables',\n",
       " 'methods used to measure risk',\n",
       " 'miscellaneous other provisions',\n",
       " 'miscellaneous other provisions [abstract]',\n",
       " 'explanation of whether entity applied fair value model or cost model to measure investment property',\n",
       " 'name of most senior parent entity producing publicly available financial statements',\n",
       " 'name of parent entity',\n",
       " 'name of reporting entity or other means of identification',\n",
       " 'name of ultimate parent of group',\n",
       " 'non-controlling interests',\n",
       " 'non-current assets',\n",
       " 'non-current assets [abstract]',\n",
       " 'non-current assets or disposal groups classified as held for sale or as held for distribution to owners',\n",
       " 'non-current liabilities',\n",
       " 'non-current liabilities [abstract]',\n",
       " 'non-current provisions for employee benefits',\n",
       " 'office equipment',\n",
       " 'office equipment [member]',\n",
       " 'onerous contracts provision',\n",
       " 'onerous contracts provision [abstract]',\n",
       " 'other adjustments for non-cash items',\n",
       " 'other adjustments for which cash effects are investing or financing cash flow',\n",
       " 'other cash and cash equivalents',\n",
       " 'other cash payments from operating activities',\n",
       " 'other cash payments to acquire equity or debt instruments of other entities, classified as investing activities',\n",
       " 'other cash payments to acquire interests in joint ventures, classified as investing activities',\n",
       " 'other cash receipts from operating activities',\n",
       " 'other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities',\n",
       " 'other cash receipts from sales of interests in joint ventures, classified as investing activities',\n",
       " 'other components of deferred tax expense (income)',\n",
       " 'other comprehensive income, before tax, available-for-sale financial assets',\n",
       " 'other comprehensive income, before tax, cash flow hedges',\n",
       " 'other comprehensive income',\n",
       " 'other comprehensive income, before tax',\n",
       " 'other comprehensive income [abstract]',\n",
       " 'other comprehensive income, net of tax, available-for-sale financial assets',\n",
       " 'other comprehensive income, net of tax, cash flow hedges',\n",
       " 'share of other comprehensive income of associates and joint ventures accounted for using equity method, net of tax',\n",
       " 'other current financial assets',\n",
       " 'other current financial liabilities',\n",
       " 'other current non-financial assets',\n",
       " 'other current non-financial liabilities',\n",
       " 'other employee expense',\n",
       " 'other equity interest',\n",
       " 'other expense, by function',\n",
       " 'other expenses, by nature',\n",
       " 'other financial assets',\n",
       " 'other financial liabilities',\n",
       " 'other gains (losses)',\n",
       " 'other income',\n",
       " 'other inflows (outflows) of cash, classified as financing activities',\n",
       " 'other inflows (outflows) of cash, classified as investing activities',\n",
       " 'other inflows (outflows) of cash, classified as operating activities',\n",
       " 'other intangible assets',\n",
       " 'other intangible assets [member]',\n",
       " 'other non-current provisions',\n",
       " 'other material actuarial assumptions',\n",
       " 'other material non-cash items',\n",
       " 'other non-current financial assets',\n",
       " 'other non-current financial liabilities',\n",
       " 'other non-current non-financial assets',\n",
       " 'other non-current non-financial liabilities',\n",
       " 'other non-financial assets',\n",
       " 'other non-financial liabilities',\n",
       " 'other property, plant and equipment',\n",
       " 'other property, plant and equipment [member]',\n",
       " 'other provisions',\n",
       " 'other provisions [abstract]',\n",
       " 'other reserves',\n",
       " 'other revenue',\n",
       " 'other reversals of provisions',\n",
       " 'other short-term employee benefits',\n",
       " 'other current provisions',\n",
       " 'other tax effects for reconciliation between accounting profit and tax expense (income)',\n",
       " 'other tax rate effects for reconciliation between accounting profit and tax expense (income)',\n",
       " 'payments for premiums and claims, annuities and other policy benefits',\n",
       " 'payments from contracts held for dealing or trading purpose',\n",
       " 'payments of other equity instruments',\n",
       " \"payments to acquire or redeem entity's shares\",\n",
       " 'payments to and on behalf of employees',\n",
       " 'payments to suppliers for goods and services',\n",
       " 'period covered by financial statements',\n",
       " 'plan assets, at fair value',\n",
       " 'post-employment benefit expense, defined contribution plans',\n",
       " 'price index movements',\n",
       " 'proceeds from government grants, classified as financing activities',\n",
       " 'proceeds from government grants, classified as investing activities',\n",
       " 'proceeds from issuing other equity instruments',\n",
       " 'proceeds from issuing shares',\n",
       " 'proceeds from sales of other long-term assets, classified as investing activities',\n",
       " 'proceeds from sales of intangible assets, classified as investing activities',\n",
       " 'proceeds from sales of property, plant and equipment, classified as investing activities',\n",
       " 'profit (loss)',\n",
       " 'profit (loss) [abstract]',\n",
       " 'profit (loss), attributable to [abstract]',\n",
       " 'profit (loss), attributable to non-controlling interests',\n",
       " 'profit (loss), attributable to ordinary equity holders of parent entity [abstract]',\n",
       " 'profit (loss), attributable to owners of parent',\n",
       " 'profit (loss) before tax',\n",
       " 'profit (loss) from continuing operations',\n",
       " 'profit (loss) from discontinued operations',\n",
       " 'disclosure of operating segments [abstract]',\n",
       " 'property, plant and equipment',\n",
       " 'property, plant and equipment [abstract]',\n",
       " 'property, plant and equipment, expenditures recognised in course of its construction',\n",
       " 'property, plant and equipment, gross carrying amount of fully depreciated assets still in use',\n",
       " 'property, plant and equipment, revaluation [abstract]',\n",
       " 'property, plant and equipment, revaluation surplus',\n",
       " 'property, plant and equipment, temporarily idle',\n",
       " 'provision for decommissioning, restoration and rehabilitation costs',\n",
       " 'provision for decommissioning, restoration and rehabilitation costs [abstract]',\n",
       " 'provisions for employee benefits',\n",
       " 'provision used, other provisions',\n",
       " 'purchase of intangible assets, classified as investing activities',\n",
       " 'purchase of other long-term assets, classified as investing activities',\n",
       " 'purchase of property, plant and equipment, classified as investing activities',\n",
       " 'range of estimates within which fair value is likely to lie for biological assets, at cost',\n",
       " 'range of estimates within which fair value is likely to lie for investment property, cost model',\n",
       " 'raw materials and consumables used',\n",
       " 'receipts from contracts held for dealing or trading purposes',\n",
       " 'receipts from premiums and claims, annuities and other policy benefits',\n",
       " 'receipts from royalties, fees, commissions and other revenue',\n",
       " 'receipts from sales of goods and rendering of services',\n",
       " 'recipes, formulae, models, designs and prototypes',\n",
       " 'recipes, formulae, models, designs and prototypes [member]',\n",
       " 'reclassification adjustments on available-for-sale financial assets, before tax',\n",
       " 'reclassification adjustments on available-for-sale financial assets, net of tax',\n",
       " 'reclassification adjustments on cash flow hedges, before tax',\n",
       " 'reclassification adjustments on cash flow hedges, net of tax',\n",
       " 'reconciliation of accounting profit multiplied by applicable tax rates [abstract]',\n",
       " 'reconciliation of average effective tax rate and applicable tax rate [abstract]',\n",
       " 'reconciliation of changes in biological assets [abstract]',\n",
       " 'reconciliation of changes in goodwill [abstract]',\n",
       " 'reconciliation of changes in intangible assets other than goodwill [abstract]',\n",
       " 'reconciliation of changes in investment property [abstract]',\n",
       " 'reconciliation of changes in other provisions [abstract]',\n",
       " 'reconciliation of changes in property, plant and equipment [abstract]',\n",
       " 'redesignated [member]',\n",
       " 'redesignated amount [member]',\n",
       " 'redesignated financial asset as available-for-sale',\n",
       " 'redesignated financial asset as at fair value through profit or loss',\n",
       " 'redesignated financial liability as at fair value through profit or loss',\n",
       " 'rental income from investment property',\n",
       " 'repayments of borrowings, classified as financing activities',\n",
       " 'description of restrictions on access to assets in funds',\n",
       " 'restructuring provision',\n",
       " 'restructuring provision [abstract]',\n",
       " 'retained earnings',\n",
       " 'revaluation increase (decrease), intangible assets other than goodwill',\n",
       " 'revaluation increase (decrease), property, plant and equipment',\n",
       " 'revaluation of intangible assets [abstract]',\n",
       " 'revenue',\n",
       " 'revenue [abstract]',\n",
       " 'revenue from construction contracts',\n",
       " 'dividend income',\n",
       " 'interest income',\n",
       " 'revenue from rendering of services',\n",
       " 'royalty income',\n",
       " 'revenue from sale of goods',\n",
       " 'reversal of inventory write-down',\n",
       " 'reversal of provisions for cost of restructuring',\n",
       " 'description of segment in which non-current asset or disposal group held for sale is presented',\n",
       " 'disclosure of geographical areas [abstract]',\n",
       " 'disclosure of products and services [abstract]',\n",
       " 'sensitivity analysis for types of market risk [text block]',\n",
       " 'profit or loss [abstract]',\n",
       " 'share of profit (loss) of associates and joint ventures accounted for using equity method',\n",
       " 'share premium',\n",
       " 'short-term deposits, classified as cash equivalents',\n",
       " 'short-term investments, classified as cash equivalents',\n",
       " 'current legal proceedings provision',\n",
       " 'current miscellaneous other provisions',\n",
       " 'current onerous contracts provision',\n",
       " 'current provision for decommissioning, restoration and rehabilitation costs',\n",
       " 'current restructuring provision',\n",
       " 'current warranty provision',\n",
       " 'statement of cash flows [abstract]',\n",
       " 'statement of changes in equity [abstract]',\n",
       " 'statement of comprehensive income [abstract]',\n",
       " 'statement of financial position [abstract]',\n",
       " \"summary quantitative data about entity's exposure to risk [text block]\",\n",
       " 'surplus (deficit) in plan',\n",
       " 'tangible exploration and evaluation assets',\n",
       " 'tangible exploration and evaluation assets [member]',\n",
       " 'tax benefit arising from previously unrecognised tax loss, tax credit or temporary difference of prior period used to reduce current tax expense',\n",
       " 'tax benefit arising from previously unrecognised tax loss, tax credit or temporary difference of prior period used to reduce deferred tax expense',\n",
       " 'tax effect from change in tax rate',\n",
       " 'tax effect of expense not deductible in determining taxable profit (tax loss)',\n",
       " 'tax effect of foreign tax rates',\n",
       " 'tax effect of revenues exempt from taxation',\n",
       " 'tax effect of tax losses',\n",
       " 'tax expense (income) at applicable tax rate',\n",
       " 'tax expense (income) relating to changes in accounting policies and errors included in profit or loss',\n",
       " 'tax rate effect from change in tax rate',\n",
       " 'tax rate effect of expense not deductible in determining taxable profit (tax loss)',\n",
       " 'tax rate effect of foreign tax rates',\n",
       " 'tax rate effect of revenues exempt from taxation',\n",
       " 'tax rate effect of tax losses',\n",
       " 'termination benefits expense',\n",
       " 'description of timing and reason for transfer between financial liabilities and equity attributable to change in redemption prohibition',\n",
       " 'trade and other payables',\n",
       " 'trade and other payables [abstract]',\n",
       " 'trade and other receivables',\n",
       " 'trade and other receivables [abstract]',\n",
       " 'transfer between financial liabilities and equity attributable to change in redemption prohibition',\n",
       " 'treasury shares',\n",
       " 'unrecognised share of losses of associates',\n",
       " 'unused provision reversed, other provisions',\n",
       " 'unused tax credits for which no deferred tax asset recognised',\n",
       " 'unused tax losses for which no deferred tax asset recognised',\n",
       " 'vehicles',\n",
       " 'vehicles [member]',\n",
       " 'wages and salaries',\n",
       " 'warranty provision',\n",
       " 'warranty provision [abstract]',\n",
       " 'other work performed by entity and capitalised',\n",
       " 'write-downs (reversals of write-downs) of inventories',\n",
       " 'write-downs (reversals of write-downs) of property, plant and equipment',\n",
       " 'disclosure of major customers [abstract]',\n",
       " 'aggregate adjustment to carrying amounts of investments reported under previous gaap',\n",
       " 'aggregate deemed cost of investments for which deemed cost is fair value',\n",
       " 'aggregate deemed cost of investments for which deemed cost is previous gaap carrying amount',\n",
       " 'equity reclassified into financial liabilities',\n",
       " 'expenses on financial assets reclassified out of financial assets at fair value through profit or loss recognised in profit or loss',\n",
       " 'explanation of facts and circumstances indicating rare situation for reclassification out of financial assets at fair value through profit or loss',\n",
       " 'fair value gains (losses) on financial assets reclassified out of available-for-sale financial assets not recognised in other comprehensive income',\n",
       " 'fair value gains (losses) on financial assets reclassified out of available-for-sale financial assets recognised in other comprehensive income',\n",
       " 'fair value gains (losses) on financial assets reclassified out of financial assets at fair value through profit or loss not recognised in profit or loss',\n",
       " 'fair value gains (losses) on financial assets reclassified out of financial assets at fair value through profit or loss recognised in profit or loss',\n",
       " 'finance income',\n",
       " 'financial assets reclassified out of available-for-sale financial assets, at fair value',\n",
       " 'financial assets reclassified out of available-for-sale financial assets, carrying amount',\n",
       " 'financial assets reclassified out of financial assets at fair value through profit or loss, at fair value',\n",
       " 'financial assets reclassified out of financial assets at fair value through profit or loss, carrying amount',\n",
       " 'financial liabilities reclassified into equity',\n",
       " 'gains (losses) on financial assets reclassified out of financial assets at fair value through profit or loss recognised in profit or loss',\n",
       " 'income on financial assets reclassified out of financial assets at fair value through profit or loss recognised in profit or loss',\n",
       " 'increase (decrease) in cash and cash equivalents before effect of exchange rate changes',\n",
       " 'length of life of limited life entity',\n",
       " 'trade and other non-current receivables',\n",
       " 'other income (expense) from subsidiaries, jointly controlled entities and associates',\n",
       " 'reclassification into available-for-sale financial assets',\n",
       " 'reclassification into held-to-maturity investments',\n",
       " 'reclassification into loans and receivables',\n",
       " 'reclassification out of available-for-sale financial assets',\n",
       " 'reclassification out of financial assets at fair value through profit or loss',\n",
       " 'reclassification out of held-to-maturity investments',\n",
       " 'reclassification out of loans and receivables',\n",
       " 'trade and other current receivables',\n",
       " 'disclosure of operating segments [table]',\n",
       " 'disclosure of products and services [table]',\n",
       " 'disclosure of geographical areas [table]',\n",
       " 'disclosure of major customers [table]',\n",
       " 'financial effect of transition from previous gaap to ifrss [axis]',\n",
       " 'geographical areas [axis]',\n",
       " 'continuing and discontinued operations [axis]',\n",
       " 'previously stated [member]',\n",
       " 'increase (decrease) due to corrections of prior period errors [member]',\n",
       " 'increase (decrease) due to changes in accounting policy [member]',\n",
       " 'currently stated [member]',\n",
       " 'previous gaap [member]',\n",
       " 'effect of transition to ifrss [member]',\n",
       " 'ifrss [member]',\n",
       " 'geographical areas [member]',\n",
       " 'continuing operations [member]',\n",
       " 'discontinued operations [member]',\n",
       " 'aggregate continuing and discontinued operations [member]',\n",
       " 'reportable segments [member]',\n",
       " 'products and services [member]',\n",
       " 'products and services [axis]',\n",
       " 'consolidated [member]',\n",
       " 'separate [member]',\n",
       " 'consolidated and separate financial statements [axis]',\n",
       " 'disposal groups classified as held for sale [member]',\n",
       " 'customers [member]',\n",
       " 'major customers [axis]',\n",
       " 'retrospective application and retrospective restatement [axis]',\n",
       " 'increase (decrease) in dividends payable through change in fair value of non-cash assets held for distribution to owners',\n",
       " 'dividends payable, non-cash assets distributions',\n",
       " 'description of nature of non-cash assets held for distribution to owners declared before financial statements authorised for issue',\n",
       " 'non-cash assets declared for distribution to owners before financial statements authorised for issue',\n",
       " 'non-cash assets declared for distribution to owners before financial statements authorised for issue, at fair value',\n",
       " 'borrowings',\n",
       " 'current borrowings',\n",
       " 'current portion of non-current borrowings',\n",
       " 'all other segments [member]',\n",
       " 'operating segments [member]',\n",
       " 'material reconciling items [member]',\n",
       " 'trade and other current payables',\n",
       " 'trade and other non-current payables',\n",
       " 'proceeds from borrowings, classified as financing activities',\n",
       " 'gains (losses) on financial assets at fair value through profit or loss',\n",
       " 'gains (losses) on financial liabilities at fair value through profit or loss',\n",
       " 'gains (losses) on financial assets at fair value through profit or loss, classified as held for trading',\n",
       " 'gains (losses) on financial liabilities at fair value through profit or loss, classified as held for trading',\n",
       " 'description of amounts of potential income tax consequences practicably determinable',\n",
       " 'description of basis of accounting for transactions between reportable segments',\n",
       " \"description of nature of differences between measurements of reportable segments' profits or losses and entity's profit or loss before income tax expense or income and discontinued operations\",\n",
       " \"description of nature of differences between measurements of reportable segments' assets and entity's assets\",\n",
       " \"description of nature of differences between measurements of reportable segments' liabilities and entity's liabilities\",\n",
       " 'description of nature of changes from prior periods in measurement methods used to determine reported segment profit or loss and effect of those changes on measure of segment profit or loss',\n",
       " 'description of nature and effect of any asymmetrical allocations to reportable segments',\n",
       " 'description of criteria used to distinguish investment property from owner-occupied property and from property held for sale in ordinary course of business',\n",
       " 'description of extent to which fair value of investment property is based on valuation by independent valuer',\n",
       " 'direct operating expense from investment property not generating rental income',\n",
       " 'reserve of cash flow hedges',\n",
       " 'reserve of exchange differences on translation',\n",
       " 'revaluation surplus',\n",
       " 'disclosure of detailed information about business combination [table]',\n",
       " 'business combinations [axis]',\n",
       " 'aggregated individually immaterial business combinations [member]',\n",
       " 'name of acquiree',\n",
       " 'description of acquiree',\n",
       " 'percentage of voting equity interests acquired',\n",
       " 'description of primary reasons for business combination',\n",
       " 'description of how acquirer obtained control of acquiree',\n",
       " 'description of factors that make up goodwill recognised',\n",
       " 'consideration transferred, acquisition-date fair value',\n",
       " 'cash transferred',\n",
       " 'other tangible or intangible assets transferred',\n",
       " 'liabilities incurred',\n",
       " 'equity interests of acquirer',\n",
       " 'number of instruments or interests issued or issuable',\n",
       " 'description of method of measuring fair value of instruments or interests',\n",
       " 'description of arrangement for contingent consideration arrangements and indemnification assets',\n",
       " 'description of basis for determining amount of payment for contingent consideration arrangements and indemnification assets',\n",
       " 'description of estimate of range of undiscounted outcomes from contingent consideration arrangements and indemnification assets',\n",
       " 'description of explanation of fact and reasons why range of outcomes from contingent consideration arrangements and indemnification assets cannot be estimated',\n",
       " 'explanation of fact that maximum amount of payment for contingent consideration arrangements and indemnification assets is unlimited',\n",
       " 'fair value of acquired receivables',\n",
       " 'gross contractual amounts receivable for acquired receivables',\n",
       " 'best estimate at acquisition date of contractual cash flows not expected to be collected for acquired receivables',\n",
       " 'description of reasons why liability cannot be measured reliably',\n",
       " 'goodwill expected to be deductible for tax purposes',\n",
       " 'description of transaction recognised separately from acquisition of assets and assumption of liabilities in business combination',\n",
       " 'description of line item in statement of comprehensive income in which gain in bargain purchase transaction is recognised',\n",
       " 'description of reasons why bargain purchase transaction resulted in gain',\n",
       " 'non-controlling interest in acquiree recognised at acquisition date',\n",
       " 'description of measurement basis for non-controlling interest in acquiree recognised at acquisition date',\n",
       " 'description of valuation techniques and significant inputs used to measure non-controlling interest in acquiree measured at fair value',\n",
       " 'acquisition-date fair value of equity interest in acquiree held by acquirer immediately before acquisition date',\n",
       " 'revenue of acquiree since acquisition date',\n",
       " 'profit (loss) of acquiree since acquisition date',\n",
       " 'revenue of combined entity as if combination occurred at beginning of period',\n",
       " 'profit (loss) of combined entity as if combination occurred at beginning of period',\n",
       " 'description of reasons why initial accounting for business combination is incomplete',\n",
       " 'description of assets, liabilities, equity interests or items of consideration for which initial accounting is incomplete',\n",
       " 'description of nature of any measurement period adjustments recognised for particular assets, liabilities, non-controlling interests or items of consideration',\n",
       " 'explanation of any changes in recognised amounts of contingent consideration',\n",
       " 'description of valuation techniques and key model inputs used to measure contingent consideration',\n",
       " 'goodwill derecognised without having previously been included in disposal group classified as held for sale',\n",
       " \"gain (loss) that relates to identifiable assets acquired or liabilities assumed in business combination and is of such size, nature or incidence that disclosure is relevant to understanding combined entity's financial statements\",\n",
       " \"explanation of gain or loss that relates to identifiable assets acquired or liabilities assumed in business combination and is of such size, nature or incidence that disclosure is relevant to understanding combined entity's financial statements\",\n",
       " 'explanation of fact and explanation of why disclosure of information on revenues and profit or loss is impracticable',\n",
       " 'explanation of which disclosures could not be made and reasons why they cannot be made if initial accounting for business combination is incomplete at time financial statements are authorised for issue',\n",
       " 'business combinations [member]',\n",
       " 'disclosure of detailed information about business combination [abstract]',\n",
       " 'number of shares authorised',\n",
       " 'number of shares issued and fully paid',\n",
       " 'number of shares issued but not fully paid',\n",
       " 'par value per share',\n",
       " 'rights, preferences and restrictions attaching to class of share capital',\n",
       " 'number of shares in entity held by entity or by its subsidiaries or associates',\n",
       " 'number of shares reserved for issue under options and contracts for sale of shares',\n",
       " 'adjustments for income tax expense',\n",
       " 'adjustments for depreciation and amortisation expense',\n",
       " 'adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss',\n",
       " 'adjustments for share-based payments',\n",
       " 'adjustments for fair value losses (gains)',\n",
       " 'description of objectives, policies and processes for managing risks arising from insurance contracts and methods used to manage those risks',\n",
       " 'disclosure of insurance risk [text block]',\n",
       " 'disclosure of sensitivity to insurance risk [text block]',\n",
       " 'sensitivity analysis to insurance risk',\n",
       " 'qualitative information about sensitivity and information about those terms and conditions of insurance contracts that have material effect',\n",
       " 'description of concentrations of insurance risk',\n",
       " 'disclosure of actual claims compared with previous estimates [text block]',\n",
       " 'disclosure of credit risk of insurance contracts [text block]',\n",
       " 'disclosure of liquidity risk of insurance contracts [text block]',\n",
       " 'disclosure of market risk of insurance contracts [text block]',\n",
       " 'disclosure of maturity analysis for derivative financial liabilities [text block]',\n",
       " 'reserve of gains and losses on remeasuring available-for-sale financial assets',\n",
       " 'current provisions',\n",
       " 'non-current provisions',\n",
       " 'provisions',\n",
       " 'disclosure of temporary difference, unused tax losses and unused tax credits [text block]',\n",
       " 'description of accounting policy for investment in associates [text block]',\n",
       " 'description of accounting policy for investments in joint ventures [text block]',\n",
       " 'fair value of investments in joint ventures for which there are quoted market prices',\n",
       " 'gains (losses) on financial assets at amortised cost',\n",
       " 'disclosure of comparative information prepared under previous gaap [abstract]',\n",
       " 'disclosure of comparative information prepared under previous gaap [table]',\n",
       " 'non-current receivables due from related parties',\n",
       " 'receivables due from related parties',\n",
       " 'current receivables due from related parties',\n",
       " 'trade payables',\n",
       " 'payables to related parties',\n",
       " 'current trade payables',\n",
       " 'current payables to related parties',\n",
       " 'non-current trade payables',\n",
       " 'non-current payables to related parties',\n",
       " 'trade and other non-current receivables [abstract]',\n",
       " 'trade and other current payables [abstract]',\n",
       " 'trade and other non-current payables [abstract]',\n",
       " 'trade and other current receivables [abstract]',\n",
       " 'principal place of business',\n",
       " 'income taxes paid (refund)',\n",
       " 'explanation of reason why it is impracticable to determine amounts for correction related to prior period errors',\n",
       " 'explanation of reason why it is impracticable to determine amounts of adjustments related to change in accounting policy',\n",
       " 'income taxes paid (refund) [abstract]',\n",
       " 'explanation of nature of requirement in ifrs and conclusion why requirement is in conflict with objective of financial statements set out in framework',\n",
       " 'explanation of adjustments that would be necessary to achieve fair presentation',\n",
       " 'accruals classified as current',\n",
       " 'accruals classified as non-current',\n",
       " 'accruals',\n",
       " 'description of nature of transferred financial assets that are not derecognised in their entirety',\n",
       " 'description of nature of risks and rewards of ownership to which entity is exposed',\n",
       " 'assets that entity continues to recognise',\n",
       " 'current provisions [abstract]',\n",
       " 'non-current provisions [abstract]',\n",
       " 'provisions [abstract]',\n",
       " 'issued capital [member]',\n",
       " 'share premium [member]',\n",
       " 'treasury shares [member]',\n",
       " 'other equity interest [member]',\n",
       " 'retained earnings [member]',\n",
       " 'equity attributable to owners of parent [member]',\n",
       " 'non-controlling interests [member]',\n",
       " 'components of equity [axis]',\n",
       " 'statement of changes in equity [table]',\n",
       " 'disclosure of detailed information about property, plant and equipment [abstract]',\n",
       " 'disclosure of detailed information about property, plant and equipment [table]',\n",
       " 'classes of property, plant and equipment [axis]',\n",
       " 'disclosure of detailed information about intangible assets [abstract]',\n",
       " 'disclosure of detailed information about intangible assets [table]',\n",
       " 'classes of intangible assets other than goodwill [axis]',\n",
       " 'disclosure of reconciliation of changes in biological assets [abstract]',\n",
       " 'disclosure of reconciliation of changes in biological assets [table]',\n",
       " 'measurement [axis]',\n",
       " 'disclosure of other provisions [abstract]',\n",
       " 'disclosure of other provisions [table]',\n",
       " 'classes of other provisions [axis]',\n",
       " 'description of nature of obligation, other provisions',\n",
       " 'description of expected timing of outflows, other provisions',\n",
       " 'indication of uncertainties of amount or timing of outflows, other provisions',\n",
       " 'asset recognised for expected reimbursement, other provisions',\n",
       " 'expected reimbursement, other provisions',\n",
       " 'disclosure of detailed information about investment property [abstract]',\n",
       " 'disclosure of detailed information about investment property [table]',\n",
       " 'disclosure of defined benefit plans [abstract]',\n",
       " 'disclosure of defined benefit plans [table]',\n",
       " 'defined benefit plans [axis]',\n",
       " 'disclosure of fair values of items used as deemed cost [table]',\n",
       " 'fair value as deemed cost [axis]',\n",
       " 'aggregate adjustment to carrying amounts reported under previous gaap [member]',\n",
       " 'aggregate of fair values [member]',\n",
       " 'property, plant and equipment fair value used as deemed cost',\n",
       " 'intangible asset fair value used as deemed cost',\n",
       " 'investment property fair value used as deemed cost',\n",
       " 'disclosure of redesignated financial assets and liabilities [table]',\n",
       " 'redesignation [axis]',\n",
       " 'disclosure of impairment loss and reversal of impairment loss [table]',\n",
       " 'goodwill [member]',\n",
       " 'other impaired assets [member]',\n",
       " 'disclosure of financial assets [abstract]',\n",
       " 'disclosure of financial assets [table]',\n",
       " 'financial assets',\n",
       " 'disclosure of financial liabilities [abstract]',\n",
       " 'disclosure of financial liabilities [table]',\n",
       " 'financial liabilities',\n",
       " 'financial assets at fair value through profit or loss, classified as held for trading',\n",
       " 'financial assets at fair value through profit or loss',\n",
       " 'held-to-maturity investments',\n",
       " 'loans and receivables',\n",
       " 'financial liabilities at fair value through profit or loss that meet definition of held for trading',\n",
       " 'equity [member]',\n",
       " 'property, plant and equipment [member]',\n",
       " 'intangible assets other than goodwill [member]',\n",
       " 'other provisions [member]',\n",
       " 'investment property [member]',\n",
       " 'fair value model [member]',\n",
       " 'defined benefit plans [member]',\n",
       " 'warranty provision [member]',\n",
       " ...]"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "L2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'pretax income'"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "L1[7].lower()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Accounting profit',\n",
       " 'Accumulated increase (decrease) in fair value of financial liability, attributable to changes in credit risk of liability',\n",
       " 'Accumulated increase (decrease) in fair value of loan or receivable, attributable to changes in credit risk of financial assets',\n",
       " 'Acquisitions through business combinations, biological assets',\n",
       " 'Acquisitions through business combinations, intangible assets other than goodwill',\n",
       " 'Acquisitions through business combinations, investment property',\n",
       " 'Acquisitions through business combinations, other provisions',\n",
       " 'Acquisitions through business combinations, property, plant and equipment',\n",
       " 'Actuarial assumption of discount rates',\n",
       " 'Actuarial assumption of expected rates of salary increases',\n",
       " 'Actuarial assumption of medical cost trend rates',\n",
       " 'Additional information about entity exposure to risk',\n",
       " 'Additional information [abstract]',\n",
       " 'Additional provisions, other provisions',\n",
       " 'Additional recognition, goodwill',\n",
       " 'Additions from acquisitions, investment property',\n",
       " 'Additions from subsequent expenditure recognised as asset, investment property',\n",
       " 'Additions, investment property [abstract]',\n",
       " 'Additions other than through business combinations, biological assets',\n",
       " 'Additions other than through business combinations, intangible assets other than goodwill',\n",
       " 'Additions other than through business combinations, investment property',\n",
       " 'Additions other than through business combinations, property, plant and equipment',\n",
       " \"Address of entity's registered office\",\n",
       " 'Amounts removed from equity and included in carrying amount of non-financial asset (liability) whose acquisition or incurrence was hedged highly probable forecast transaction, net of tax',\n",
       " 'Adjustments for decrease (increase) in inventories',\n",
       " 'Adjustments for decrease (increase) in other operating receivables',\n",
       " 'Adjustments for decrease (increase) in trade accounts receivable',\n",
       " 'Adjustments for increase (decrease) in other operating payables',\n",
       " 'Adjustments for increase (decrease) in trade accounts payable',\n",
       " 'Adjustments for losses (gains) on disposal of non-current assets',\n",
       " 'Adjustments for provisions',\n",
       " 'Adjustments to reconcile profit (loss)',\n",
       " 'Adjustments to reconcile profit (loss) [abstract]',\n",
       " 'Adjustments for undistributed profits of associates',\n",
       " 'Adjustments for unrealised foreign exchange losses (gains)',\n",
       " 'Administrative expenses',\n",
       " 'Current and deferred tax relating to items credited (charged) directly to equity',\n",
       " 'Current and deferred tax relating to items charged or credited directly to equity [abstract]',\n",
       " 'Current tax relating to items credited (charged) directly to equity',\n",
       " 'Allowance account for credit losses of financial assets',\n",
       " 'Amortisation, intangible assets other than goodwill',\n",
       " 'Amortisation method, intangible assets other than goodwill',\n",
       " 'Analysis of age of financial assets that are past due but not impaired [text block]',\n",
       " 'Analysis of financial assets that are individually determined to be impaired [text block]',\n",
       " 'Analysis of income and expense [abstract]',\n",
       " 'Applicable tax rate',\n",
       " 'Assets',\n",
       " 'Assets [abstract]',\n",
       " 'Available-for-sale financial assets [abstract]',\n",
       " 'Average effective tax rate',\n",
       " 'Balances with banks',\n",
       " 'Other banking arrangements, classified as cash equivalents',\n",
       " 'Bank overdrafts',\n",
       " 'Basic earnings (loss) per share',\n",
       " 'Basic earnings (loss) per share from continuing operations',\n",
       " 'Basic earnings (loss) per share from discontinued operations',\n",
       " 'Basic earnings per share [abstract]',\n",
       " 'Description of basis for attributing revenues from external customers to individual countries',\n",
       " 'Biological assets',\n",
       " 'Biological assets [member]',\n",
       " 'Borrowing costs capitalised',\n",
       " 'Brand names',\n",
       " 'Brand names [member]',\n",
       " 'Capitalisation rate of borrowing costs eligible for capitalisation',\n",
       " 'Cash advances and loans made to other parties, classified as investing activities',\n",
       " 'Cash and cash equivalents',\n",
       " 'Cash and cash equivalents [abstract]',\n",
       " 'Cash flow hedges [abstract]',\n",
       " 'Cash flows from continuing and discontinued operations [abstract]',\n",
       " 'Cash flows from losing control of subsidiaries or other businesses, classified as investing activities',\n",
       " 'Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities',\n",
       " 'Cash flows from (used in) financing activities',\n",
       " 'Cash flows from (used in) financing activities [abstract]',\n",
       " 'Cash flows from (used in) financing activities, continuing operations',\n",
       " 'Cash flows from (used in) financing activities, discontinued operations',\n",
       " 'Cash flows from (used in) investing activities',\n",
       " 'Cash flows from (used in) investing activities [abstract]',\n",
       " 'Cash flows from (used in) investing activities, continuing operations',\n",
       " 'Cash flows from (used in) investing activities, discontinued operations',\n",
       " 'Cash flows from (used in) operating activities',\n",
       " 'Cash flows from (used in) operating activities [abstract]',\n",
       " 'Cash flows from (used in) operating activities, continuing operations',\n",
       " 'Cash flows from (used in) operating activities, discontinued operations',\n",
       " 'Cash on hand',\n",
       " 'Cash receipts from repayment of advances and loans made to other parties, classified as investing activities',\n",
       " 'Increase (decrease) in amount recognised for pre-acquisition deferred tax asset',\n",
       " 'Increase (decrease) in biological assets',\n",
       " 'Changes in biological assets [abstract]',\n",
       " 'Increase (decrease) in equity',\n",
       " 'Changes in equity [abstract]',\n",
       " 'Description of changes in exposure to risk',\n",
       " 'Increase (decrease) in fair value of financial liability, attributable to changes in credit risk of liability',\n",
       " 'Increase (decrease) in fair value of loans or receivables, attributable to changes in credit risk of financial assets',\n",
       " 'Increase (decrease) in goodwill',\n",
       " 'Changes in goodwill [abstract]',\n",
       " 'Increase (decrease) in intangible assets other than goodwill',\n",
       " 'Changes in intangible assets other than goodwill [abstract]',\n",
       " 'Decrease (increase) in inventories of finished goods and work in progress',\n",
       " 'Increase (decrease) in investment property',\n",
       " 'Changes in investment property [abstract]',\n",
       " 'Description of changes in methods and assumptions used in preparing sensitivity analysis',\n",
       " 'Description of changes in methods used to measure risk',\n",
       " 'Description of changes in objectives, policies and processes for managing risk',\n",
       " 'Increase (decrease) in other provisions',\n",
       " 'Changes in other provisions [abstract]',\n",
       " 'Increase (decrease) in property, plant and equipment',\n",
       " 'Changes in property, plant and equipment [abstract]',\n",
       " 'Description of circumstances leading to reversals of inventory write-down',\n",
       " 'Classes of cash receipts from operating activities [abstract]',\n",
       " 'Classes of employee benefits expense [abstract]',\n",
       " 'Classes of other provisions [abstract]',\n",
       " 'Comprehensive income',\n",
       " 'Comprehensive income [abstract]',\n",
       " 'Comprehensive income attributable to [abstract]',\n",
       " 'Comprehensive income, attributable to non-controlling interests',\n",
       " 'Comprehensive income, attributable to owners of parent',\n",
       " 'Computer software',\n",
       " 'Computer software [member]',\n",
       " 'Description of concentrations of risk',\n",
       " 'Construction in progress',\n",
       " 'Construction in progress [member]',\n",
       " 'Copyrights, patents and other industrial property rights, service and operating rights',\n",
       " 'Copyrights, patents and other industrial property rights, service and operating rights [member]',\n",
       " 'Cost of inventories recognised as expense during period',\n",
       " 'Cost of sales',\n",
       " 'Country of incorporation',\n",
       " 'Cumulative change in fair value recognised in profit or loss on sales of investment property between pools of assets measured using different models',\n",
       " 'Cumulative unrecognised share of losses of associates',\n",
       " 'Current assets',\n",
       " 'Current assets [abstract]',\n",
       " 'Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners',\n",
       " 'Current liabilities',\n",
       " 'Current liabilities [abstract]',\n",
       " 'Current liabilities other than liabilities included in disposal groups classified as held for sale',\n",
       " 'Current provisions for employee benefits',\n",
       " 'Current tax assets',\n",
       " 'Current tax expense (income)',\n",
       " 'Current tax liabilities',\n",
       " 'Decrease due to harvest, biological assets',\n",
       " 'Decrease through classified as held for sale, biological assets',\n",
       " 'Decrease through classified as held for sale, goodwill',\n",
       " 'Decrease through classified as held for sale, intangible assets other than goodwill',\n",
       " 'Decrease through classified as held for sale, investment property',\n",
       " 'Decrease through classified as held for sale, property, plant and equipment',\n",
       " 'Deductible temporary differences for which no deferred tax asset is recognised',\n",
       " 'Deferred tax assets',\n",
       " 'Deferred tax assets and liabilities [abstract]',\n",
       " 'Deferred tax expense arising from write-down or reversal of write-down of deferred tax asset',\n",
       " 'Deferred tax expense (income)',\n",
       " 'Deferred tax expense (income) [abstract]',\n",
       " 'Deferred tax expense (income) relating to origination and reversal of temporary differences',\n",
       " 'Deferred tax expense (income) relating to tax rate changes or imposition of new taxes',\n",
       " 'Deferred tax liabilities',\n",
       " 'Deferred tax liability (asset)',\n",
       " 'Deferred tax relating to items credited (charged) directly to equity',\n",
       " 'Defined benefit obligation, at present value',\n",
       " 'Depreciation and amortisation expense',\n",
       " 'Depreciation, biological assets',\n",
       " 'Depreciation, investment property',\n",
       " 'Depreciation method, biological assets, at cost',\n",
       " 'Depreciation method, investment property, cost model',\n",
       " 'Depreciation method, property, plant and equipment',\n",
       " 'Depreciation, property, plant and equipment',\n",
       " 'Description of accounting policy for exploration and evaluation expenditures [text block]',\n",
       " 'Description of accounting policy for government grants [text block]',\n",
       " 'Description of accounting policy for insurance contracts and related assets, liabilities, income and expense [text block]',\n",
       " 'Description of accounting policy for measuring inventories [text block]',\n",
       " 'Description of accounting policy for recognition of revenue [text block]',\n",
       " 'Description of acquisition of entity by means of equity issue',\n",
       " 'Description of biological assets',\n",
       " 'Description of biological assets previously measured at cost',\n",
       " 'Description of biological assets where fair value information is unreliable',\n",
       " 'Description of changes in plan to sell non-current asset or disposal group held for sale',\n",
       " 'Description of collateral held as security and other credit enhancements and their financial effect in respect of amount that best represents maximum exposure',\n",
       " \"Description of terms and conditions associated with entity's use of collateral permitted to be sold or repledged in absence of default by owner of collateral\",\n",
       " 'Description of compliance with IFRSs if applied for interim financial report',\n",
       " 'Description of conversion of debt to equity',\n",
       " 'Description of details of defaults during period of principal, interest, sinking fund, or redemption terms of loans payable',\n",
       " 'Description of event or change in circumstances that caused recognition of deferred tax benefits acquired in business combination after acquisition date',\n",
       " 'Description of exposure to risk',\n",
       " 'Fair value of investments in associates for which there are quoted market prices',\n",
       " 'Fair value of property, plant and equipment materially different from carrying amount',\n",
       " 'Financial assets pledged as collateral for liabilities or contingent liabilities',\n",
       " 'Description of financial instruments designated as hedging instruments',\n",
       " 'Description of financial risk management related to agricultural activity',\n",
       " 'Description of fully amortised intangible assets',\n",
       " 'Description of functional currency',\n",
       " 'Description of investment property where fair value information is unreliable, cost model',\n",
       " 'Key management personnel compensation',\n",
       " 'Key management personnel compensation, post-employment benefits',\n",
       " 'Key management personnel compensation, share-based payment',\n",
       " 'Key management personnel compensation, short-term employee benefits',\n",
       " 'Key management personnel compensation, termination benefits',\n",
       " 'Disclosure of how entity manages liquidity risk [text block]',\n",
       " 'Description of nature of accounting errors in prior periods [text block]',\n",
       " 'Description of nature and amount of change in estimate during final interim period',\n",
       " 'Description of nature of assets obtained by taking possession of collateral or calling on other credit enhancements',\n",
       " 'Description of nature and extent of government grants for agricultural activity recognised in financial statements',\n",
       " 'Description of nature and extent of government grants recognised in financial statements',\n",
       " 'Description of nature and financial effect of business combinations after reporting period before statements authorised for issue',\n",
       " 'Description of nature and financial effect of business combinations during period',\n",
       " 'Description of nature and purpose of reserves within equity',\n",
       " 'Description of nature of activities of biological assets',\n",
       " 'Description of nature of contingent assets',\n",
       " \"Description of nature of entity's operations and principal activities\",\n",
       " 'Description of nature of financial statements',\n",
       " 'Description of nature of interest in funds',\n",
       " 'Description of nature of necessary adjustments to provide comparative information',\n",
       " 'Description of nature of non-adjusting event after reporting period',\n",
       " 'Description of nature of reclassifications or changes in presentation',\n",
       " 'Description of nature of risks being hedged',\n",
       " 'Description of non-current asset or disposal group held for sale which were sold or reclassified',\n",
       " 'Description of objectives, policies and processes for managing risk',\n",
       " 'Description of other accounting policies relevant to understanding of financial statements [text block]',\n",
       " 'Description of periods when cash flows affect profit or loss',\n",
       " 'Description of periods when cash flows expected to occur',\n",
       " 'Description of policies for disposal or for use in operation of assets obtained by taking possession of collateral or other credit enhancement [text block]',\n",
       " 'Description of presentation currency',\n",
       " 'Description of reason for change in functional currency',\n",
       " 'Description of reason for reclassifications or changes in presentation',\n",
       " 'Description of reason for using longer or shorter reporting period',\n",
       " 'Description of reasons why presumption investor does not have significant influence is overcome when its interest in investee is less than twenty per cent',\n",
       " 'Description of reasons why presumption investor has significant influence is overcome when its interest in investee is more than twenty per cent',\n",
       " 'Description of reason why fair value of goods or services received cannot be reliably estimated',\n",
       " 'Description of fact that amounts presented in financial statements are not entirely comparable',\n",
       " 'Description of reason why presentation currency is different from functional currency',\n",
       " 'Description of reason why reclassification of comparative amounts is impracticable',\n",
       " 'Description of reason why using different reporting date or period for associate',\n",
       " 'Description of redesignated financial assets',\n",
       " 'Description of redesignated financial liabilities',\n",
       " 'Share of contingent liabilities of associates incurred jointly with other investors',\n",
       " 'Description of significant intangible assets controlled by entity but not recognised',\n",
       " 'Description of transactions after reporting period that significantly change number of ordinary shares outstanding',\n",
       " 'Description of transactions after reporting period that significantly change number of potential ordinary shares outstanding',\n",
       " 'Description of type of hedge',\n",
       " 'Description of type of plan',\n",
       " 'Description of types of products and services from which each reportable segment derives its revenues',\n",
       " 'Description of unfulfilled conditions and other contingencies attached to government grant for agricultural activity',\n",
       " 'Designated financial liabilities at fair value through profit or loss [abstract]',\n",
       " 'Designated loans or receivables at fair value through profit or loss [abstract]',\n",
       " 'Explanation of determination of fair value of goods or services received or fair value of equity instruments granted on share-based payments',\n",
       " 'Difference between carrying amount of financial liability and amount contractually required to pay at maturity to holder of obligation',\n",
       " 'Diluted earnings (loss) per share',\n",
       " 'Diluted earnings (loss) per share from continuing operations',\n",
       " 'Diluted earnings (loss) per share from discontinued operations',\n",
       " 'Diluted earnings per share [abstract]',\n",
       " 'Direct operating expense from investment property generating rental income',\n",
       " 'Disclosure of additional information about understanding financial position and liquidity of entity [text block]',\n",
       " 'Disclosure of amounts arising from insurance contracts [text block]',\n",
       " 'Disclosure of biological assets, agriculture produce at point of harvest and government grants related to biological assets [text block]',\n",
       " 'Disclosure of borrowing costs [text block]',\n",
       " 'Disclosure of business combinations [text block]',\n",
       " 'Disclosure of cash flow statement [text block]',\n",
       " 'Disclosure of changes in accounting policies, accounting estimates and errors [text block]',\n",
       " 'Disclosure of classes of share capital [text block]',\n",
       " 'Disclosure of comparative information prepared under previous GAAP [text block]',\n",
       " 'Description of compound financial instruments with multiple embedded derivatives',\n",
       " 'Disclosure of contingent liabilities [text block]',\n",
       " 'Disclosure of defined benefit plans [text block]',\n",
       " 'Disclosure of earnings per share [text block]',\n",
       " 'Disclosure of effect of changes in foreign exchange rates [text block]',\n",
       " \"Disclosure of entity's operating segments [text block]\",\n",
       " 'Disclosure of events after reporting period [text block]',\n",
       " 'Disclosure of exploration and evaluation assets [text block]',\n",
       " 'Disclosure of information about possible differences between carrying amount and fair value of contracts described in IFRS 7.29 b and IFRS 7.29 c [text block]',\n",
       " 'Disclosure of fair values of items used as deemed cost [text block]',\n",
       " 'Disclosure of financial assets that are either past due or impaired [text block]',\n",
       " 'Disclosure of transferred financial assets that are not derecognised in their entirety [text block]',\n",
       " 'Disclosure of general information about financial statements [text block]',\n",
       " 'Explanation of goodwill not allocated to cash-generating unit',\n",
       " 'Disclosure of government grants [text block]',\n",
       " 'Disclosure of hedge accounting [text block]',\n",
       " 'Disclosure of hyperinflationary reporting [text block]',\n",
       " 'Disclosure of impairment loss and reversal of impairment loss [text block]',\n",
       " 'Disclosure of income tax [text block]',\n",
       " 'Description of instruments with potential future dilutive effect not included in calculation of diluted earnings per share',\n",
       " 'Disclosure of insurance contracts [text block]',\n",
       " 'Disclosure of intangible assets [text block]',\n",
       " 'Disclosure of interest in funds [text block]',\n",
       " 'Disclosure of interim financial reporting [text block]',\n",
       " 'Disclosure of inventories [text block]',\n",
       " 'Disclosure of nature and extent of risks arising from insurance contracts [text block]',\n",
       " 'Description of nature of potential income tax consequences that would result from payment of dividend',\n",
       " 'Disclosure of non-adjusting events after reporting period [text block]',\n",
       " 'Disclosure of notes and other explanatory information [text block]',\n",
       " 'Disclosure of number and weighted average exercise prices of share options [text block]',\n",
       " 'Disclosure of objectives, policies and processes for managing capital [text block]',\n",
       " 'Disclosure of other provisions, contingent liabilities and contingent assets [text block]',\n",
       " 'Disclosure of property, plant and equipment [text block]',\n",
       " 'Description of evidence supporting recognition of deferred tax asset when utilisation is dependent on future taxable profits in excess of profits from reversal of taxable temporary differences and entity has suffered loss in jurisdiction to which deferred tax asset relates',\n",
       " 'Disclosure of redemption prohibition, transfer between financial liabilities and equity [text block]',\n",
       " 'Disclosure of redesignated financial assets and liabilities [text block]',\n",
       " 'Disclosure of related party [text block]',\n",
       " 'Disclosure of reserves within equity [text block]',\n",
       " 'Disclosure of revenue [text block]',\n",
       " 'Disclosure of major customers [text block]',\n",
       " 'Disclosure of share-based payment arrangements [text block]',\n",
       " 'Disclosure of share capital, reserves and other equity interest [text block]',\n",
       " 'Disclosure of significant adjustments to valuation obtained [text block]',\n",
       " 'Cash and cash equivalents held by entity unavailable for use by group',\n",
       " 'Disclosure of transactions between related parties [text block]',\n",
       " 'Explanation of whether default was remedied or terms of loans payable were renegotiated before financial statements were authorised for issue',\n",
       " 'Disposals, biological assets',\n",
       " 'Disposals, intangible assets other than goodwill',\n",
       " 'Disposals, investment property',\n",
       " 'Disposals, property, plant and equipment',\n",
       " 'Distribution costs',\n",
       " 'Dividends recognised as distributions to owners',\n",
       " 'Dividends paid, classified as financing activities',\n",
       " 'Dividends paid, classified as operating activities',\n",
       " 'Dividends received, classified as investing activities',\n",
       " 'Dividends received, classified as operating activities',\n",
       " 'Domicile of entity',\n",
       " 'Earnings per share [abstract]',\n",
       " 'Effective dates of revaluation, intangible assets other than goodwill',\n",
       " 'Effective dates of revaluation, property, plant and equipment',\n",
       " 'Effect of exchange rate changes on cash and cash equivalents',\n",
       " 'Effect of exchange rate changes on cash and cash equivalents [abstract]',\n",
       " 'Employee benefits expense',\n",
       " 'Equity',\n",
       " 'Equity [abstract]',\n",
       " 'Equity and liabilities',\n",
       " 'Equity and liabilities [abstract]',\n",
       " 'Equity attributable to owners of parent',\n",
       " 'Exchange differences on translation [abstract]',\n",
       " 'Expenses, by nature',\n",
       " 'Expenses by nature [abstract]',\n",
       " 'Expense of restructuring activities',\n",
       " 'Commitments for development or acquisition of biological assets',\n",
       " 'Explanation of assets acquired by way of government grant and initially recognised at fair value',\n",
       " 'Explanation of sources of estimation uncertainty with significant risk of causing material adjustment',\n",
       " 'Explanation of process used to determine assumptions to measure recognised assets, liabilities, income and expense arising from insurance contracts',\n",
       " 'Explanation of body of authorisation',\n",
       " 'Explanation of change in name of reporting entity or other means of identification from end of preceding reporting period',\n",
       " 'Explanation of changes in applicable tax rates to previous accounting period',\n",
       " 'Contractual commitments for acquisition of intangible assets',\n",
       " 'Contractual commitments for acquisition of property, plant and equipment',\n",
       " 'Explanation of contractual obligations to purchase, construct or develop investment property or for repairs, maintenance or enhancements',\n",
       " 'Cumulative preference dividends not recognised',\n",
       " 'Explanation of departure from IFRS',\n",
       " 'Explanation of direct measurement of fair value of goods or services received',\n",
       " 'Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners',\n",
       " 'Explanation of effect of change for biological asset for which fair value becomes reliably measurable',\n",
       " 'Explanation of effect of changes in assumptions to measure insurance assets and insurance liabilities',\n",
       " 'Explanation of effect of changes in plan to sell non-current asset or disposal group held for sale on results of operations for current period',\n",
       " 'Explanation of effect of changes in plan to sell non-current asset or disposal group held for sale on results of operations for prior period',\n",
       " 'Explanation of effect of transition on reported cash flows',\n",
       " 'Explanation of effect of transition on reported financial performance',\n",
       " 'Explanation of effect of transition on reported financial position',\n",
       " 'Explanation of estimated financial effect of contingent assets',\n",
       " 'Explanation of facts and circumstances of sale or reclassification and expected disposal, manner and timing',\n",
       " 'Explanation of financial effect of adjustments related to business combinations',\n",
       " 'Explanation of financial effect of departure from IFRS',\n",
       " 'Description of line item(s) in profit or loss in which gain (loss) is recognised when control of subsidiary is lost',\n",
       " 'Explanation of interest income reported net of interest expense',\n",
       " 'Inventories pledged as security for liabilities',\n",
       " 'Explanation of investing and financing transactions not requiring use of cash or cash equivalents',\n",
       " \"Explanation of management judgements in applying entity's accounting policies with significant effect on recognised amounts\",\n",
       " 'Explanation of why revenues from external customers for each product and service, or each group of similar products and services, are not reported',\n",
       " 'Explanation of new standards or interpretations not applied',\n",
       " \"Explanation of fact that entity's owners or others have power to amend financial statements after issue\",\n",
       " 'Property, plant and equipment, pledged as security',\n",
       " 'Explanation of relationships between parent and subsidiaries',\n",
       " 'Explanation of restrictions on distribution of revaluation surplus for intangible assets',\n",
       " 'Explanation of significant decrease in level of government grants for agricultural activity',\n",
       " 'Consideration paid (received)',\n",
       " 'Explanation of unfulfilled conditions and other contingencies attaching to government assistance',\n",
       " 'Explanation of why fair value becomes reliable for biological assets previously measured at cost',\n",
       " 'Explanation of why fair value cannot be reliably measured for biological assets, at cost',\n",
       " 'Explanation of why fair value cannot be reliably measured for investment property, cost model',\n",
       " 'Explanation of why entity not regarded as going concern',\n",
       " \"Description of factors used to identify entity's reportable segments\",\n",
       " 'Fee income and expense [abstract]',\n",
       " 'Fee income (expense) arising from financial assets or financial liabilities not at fair value through profit or loss',\n",
       " 'Fee income (expense) arising from trust and fiduciary activities',\n",
       " 'Finance costs',\n",
       " 'Financial assets available-for-sale',\n",
       " 'Financial instruments designated as hedging instruments, at fair value',\n",
       " 'Financial liabilities at amortised cost',\n",
       " 'Financial liabilities at fair value through profit or loss',\n",
       " 'Disclosure of fair values of items used as deemed cost [abstract]',\n",
       " 'Disclosure of redesignated financial assets and liabilities [abstract]',\n",
       " 'Fixtures and fittings',\n",
       " 'Fixtures and fittings [member]',\n",
       " 'Gains (losses) on available-for-sale financial assets',\n",
       " 'Gains (losses) on cash flow hedges, before tax',\n",
       " 'Gains (losses) on cash flow hedges, net of tax',\n",
       " 'Gains (losses) on disposals of investments',\n",
       " 'Gains (losses) on disposals of other non-current assets',\n",
       " 'Gains (losses) on disposals of property, plant and equipment',\n",
       " 'Foreign exchange gain (loss)',\n",
       " 'Gains (losses) on fair value adjustment, biological assets',\n",
       " 'Gains (losses) on fair value adjustment, investment property',\n",
       " 'Gains (losses) on financial instruments [abstract]',\n",
       " 'Gains (losses) on financial liabilities at amortised cost',\n",
       " 'Gains (losses) on hedged item attributable to hedged risk, fair value hedges',\n",
       " 'Gains (losses) on hedging instrument, fair value hedges',\n",
       " 'Gains (losses) on held-to-maturity investments',\n",
       " 'Gains (losses) on ineffectiveness of cash flow hedges recognised in profit or loss',\n",
       " 'Gains (losses) on litigation settlements',\n",
       " 'Gains (losses) on loans and receivables',\n",
       " 'Gains (losses) on net monetary position',\n",
       " 'Gains (losses) on remeasuring available-for-sale financial assets, before tax',\n",
       " 'Gains (losses) on remeasuring available-for-sale financial assets, net of tax',\n",
       " 'Gains (losses) recognised when control of subsidiary is lost',\n",
       " 'Goodwill',\n",
       " 'Gross profit',\n",
       " 'Description of identity of price index',\n",
       " 'Disclosure of impairment loss and reversal of impairment loss [abstract]',\n",
       " 'Impairment loss recognised in other comprehensive income',\n",
       " 'Impairment loss recognised in other comprehensive income, intangible assets other than goodwill',\n",
       " 'Impairment loss recognised in other comprehensive income, property, plant and equipment',\n",
       " 'Impairment loss recognised in profit or loss',\n",
       " 'Impairment loss recognised in profit or loss, biological assets',\n",
       " 'Impairment loss recognised in profit or loss, goodwill',\n",
       " 'Impairment loss recognised in profit or loss, intangible assets other than goodwill',\n",
       " 'Impairment loss recognised in profit or loss, investment property',\n",
       " 'Impairment loss recognised in profit or loss, property, plant and equipment',\n",
       " 'Impairment loss on financial assets',\n",
       " 'Impairment loss (reversal of impairment loss) recognised in profit or loss',\n",
       " 'Reversal of impairment loss recognised in other comprehensive income',\n",
       " 'Reversal of impairment loss recognised in other comprehensive income, intangible assets other than goodwill',\n",
       " 'Reversal of impairment loss recognised in other comprehensive income, property, plant and equipment',\n",
       " 'Reversal of impairment loss recognised in profit or loss',\n",
       " 'Reversal of impairment loss recognised in profit or loss, biological assets',\n",
       " 'Reversal of impairment loss recognised in profit or loss, intangible assets other than goodwill',\n",
       " 'Reversal of impairment loss recognised in profit or loss, investment property',\n",
       " 'Reversal of impairment loss recognised in profit or loss, property, plant and equipment',\n",
       " 'Income, expense, gains or losses of financial instruments [abstract]',\n",
       " 'Income tax consequences of dividends proposed or declared before financial statements authorised for issue not recognised as liability',\n",
       " 'Income taxes paid (refund), classified as financing activities',\n",
       " 'Income taxes paid (refund), classified as investing activities',\n",
       " 'Income taxes paid (refund), classified as operating activities',\n",
       " 'Income tax relating to components of other comprehensive income',\n",
       " 'Income tax relating to components of other comprehensive income [abstract]',\n",
       " 'Income tax relating to share of other comprehensive income of associates and joint ventures accounted for using equity method',\n",
       " 'Increase (decrease) in allowance account for credit losses of financial assets',\n",
       " 'Increase (decrease) through change in discount rate, other provisions',\n",
       " 'Increase (decrease) through net exchange differences, biological assets',\n",
       " 'Increase (decrease) through net exchange differences, goodwill',\n",
       " 'Increase (decrease) through net exchange differences, intangible assets other than goodwill',\n",
       " 'Increase (decrease) through net exchange differences, investment property',\n",
       " 'Increase (decrease) through net exchange differences, other provisions',\n",
       " 'Increase (decrease) through net exchange differences, property, plant and equipment',\n",
       " 'Increase through adjustments arising from passage of time, other provisions',\n",
       " 'Increase (decrease) through other changes, biological assets',\n",
       " 'Increase (decrease) through other changes, goodwill',\n",
       " 'Increase (decrease) through transfers and other changes, intangible assets other than goodwill',\n",
       " 'Increase (decrease) through transfers and other changes, other provisions',\n",
       " 'Increase (decrease) through transfers and other changes, property, plant and equipment',\n",
       " 'Indication of other forms of government assistance with direct benefits for entity',\n",
       " 'Information about contingent assets that disclosure is not practicable',\n",
       " 'Information about contingent liabilities that disclosure is not practicable',\n",
       " 'Information about credit quality of neither past due nor impaired financial assets [text block]',\n",
       " 'Information about major customers',\n",
       " 'Intangible assets other than goodwill',\n",
       " 'Intangible assets other than goodwill [abstract]',\n",
       " 'Intangible assets other than goodwill, revaluation surplus',\n",
       " 'Intangible assets under development',\n",
       " 'Intangible assets under development [member]',\n",
       " 'Intangible exploration and evaluation assets',\n",
       " 'Intangible exploration and evaluation assets [member]',\n",
       " 'Interest expense',\n",
       " 'Interest expense for financial liabilities not at fair value through profit or loss',\n",
       " 'Interest income and interest expense for financial assets or financial liabilities not at fair value through profit or loss [abstract]',\n",
       " 'Interest income for financial assets not at fair value through profit or loss',\n",
       " 'Interest income on impaired financial assets accrued',\n",
       " 'Interest income on impaired financial assets accrued [abstract]',\n",
       " 'Interest paid, classified as financing activities',\n",
       " 'Interest paid, classified as operating activities',\n",
       " 'Interest received, classified as investing activities',\n",
       " 'Interest received, classified as operating activities',\n",
       " 'Interest income (expense)',\n",
       " \"Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested\",\n",
       " 'Current inventories',\n",
       " 'Inventories, at fair value less costs to sell',\n",
       " 'Description of inventory cost formulas',\n",
       " 'Inventory write-down',\n",
       " 'Investments accounted for using equity method',\n",
       " 'Investment property',\n",
       " 'Issued capital',\n",
       " 'Issue of equity',\n",
       " 'Land and buildings',\n",
       " 'Land and buildings [member]',\n",
       " 'Legal form of entity',\n",
       " 'Legal proceedings provision',\n",
       " 'Legal proceedings provision [abstract]',\n",
       " 'Level of price index',\n",
       " 'Level of rounding used in financial statements',\n",
       " 'Liabilities',\n",
       " 'Liabilities [abstract]',\n",
       " 'Liabilities from share-based payment transactions',\n",
       " 'Liabilities included in disposal groups classified as held for sale',\n",
       " 'Licences and franchises',\n",
       " 'Licences and franchises [member]',\n",
       " 'Description of objective of method used and limitations that may result in information not fully reflecting fair value of assets and liabilities involved',\n",
       " 'Description of line item(s) in statement of comprehensive income in which amortisation of intangible assets is included',\n",
       " 'Loans payable in default',\n",
       " 'Non-current legal proceedings provision',\n",
       " 'Non-current miscellaneous other provisions',\n",
       " 'Non-current onerous contracts provision',\n",
       " 'Non-current provision for decommissioning, restoration and rehabilitation costs',\n",
       " 'Non-current restructuring provision',\n",
       " 'Non-current warranty provision',\n",
       " 'Machinery',\n",
       " 'Machinery [member]',\n",
       " 'Major components of tax expense (income) [abstract]',\n",
       " 'Management conclusion on fair presentation as consequence of departure',\n",
       " 'Mastheads and publishing titles',\n",
       " 'Mastheads and publishing titles [member]',\n",
       " 'Material income and expense [abstract]',\n",
       " 'Disclosure of maturity analysis for non-derivative financial liabilities [text block]',\n",
       " 'Maximum exposure to credit risk',\n",
       " 'Maximum exposure to credit risk of loans or receivables',\n",
       " 'Measurement bases, property, plant and equipment',\n",
       " 'Description of methods and assumptions used in preparing sensitivity analysis',\n",
       " 'Description of methods of translation used to determine supplementary information',\n",
       " 'Description of methods to determine amount of changes in fair value of financial assets and financial liabilities attributable to changes in credit risk',\n",
       " 'Description of method, parameters and assumptions used in preparing sensitivity analysis reflecting interdependencies between risk variables',\n",
       " 'Methods used to measure risk',\n",
       " 'Miscellaneous other provisions',\n",
       " 'Miscellaneous other provisions [abstract]',\n",
       " 'Explanation of whether entity applied fair value model or cost model to measure investment property',\n",
       " 'Name of most senior parent entity producing publicly available financial statements',\n",
       " 'Name of parent entity',\n",
       " 'Name of reporting entity or other means of identification',\n",
       " 'Name of ultimate parent of group',\n",
       " 'Non-controlling interests',\n",
       " 'Non-current assets',\n",
       " 'Non-current assets [abstract]',\n",
       " 'Non-current assets or disposal groups classified as held for sale or as held for distribution to owners',\n",
       " 'Non-current liabilities',\n",
       " 'Non-current liabilities [abstract]',\n",
       " 'Non-current provisions for employee benefits',\n",
       " 'Office equipment',\n",
       " 'Office equipment [member]',\n",
       " 'Onerous contracts provision',\n",
       " 'Onerous contracts provision [abstract]',\n",
       " 'Other adjustments for non-cash items',\n",
       " 'Other adjustments for which cash effects are investing or financing cash flow',\n",
       " 'Other cash and cash equivalents',\n",
       " 'Other cash payments from operating activities',\n",
       " 'Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities',\n",
       " 'Other cash payments to acquire interests in joint ventures, classified as investing activities',\n",
       " 'Other cash receipts from operating activities',\n",
       " 'Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities',\n",
       " 'Other cash receipts from sales of interests in joint ventures, classified as investing activities',\n",
       " 'Other components of deferred tax expense (income)',\n",
       " 'Other comprehensive income, before tax, available-for-sale financial assets',\n",
       " 'Other comprehensive income, before tax, cash flow hedges',\n",
       " 'Other comprehensive income',\n",
       " 'Other comprehensive income, before tax',\n",
       " 'Other comprehensive income [abstract]',\n",
       " 'Other comprehensive income, net of tax, available-for-sale financial assets',\n",
       " 'Other comprehensive income, net of tax, cash flow hedges',\n",
       " 'Share of other comprehensive income of associates and joint ventures accounted for using equity method, net of tax',\n",
       " 'Other current financial assets',\n",
       " 'Other current financial liabilities',\n",
       " 'Other current non-financial assets',\n",
       " 'Other current non-financial liabilities',\n",
       " 'Other employee expense',\n",
       " 'Other equity interest',\n",
       " 'Other expense, by function',\n",
       " 'Other expenses, by nature',\n",
       " 'Other financial assets',\n",
       " 'Other financial liabilities',\n",
       " 'Other gains (losses)',\n",
       " 'Other income',\n",
       " 'Other inflows (outflows) of cash, classified as financing activities',\n",
       " 'Other inflows (outflows) of cash, classified as investing activities',\n",
       " 'Other inflows (outflows) of cash, classified as operating activities',\n",
       " 'Other intangible assets',\n",
       " 'Other intangible assets [member]',\n",
       " 'Other non-current provisions',\n",
       " 'Other material actuarial assumptions',\n",
       " 'Other material non-cash items',\n",
       " 'Other non-current financial assets',\n",
       " 'Other non-current financial liabilities',\n",
       " 'Other non-current non-financial assets',\n",
       " 'Other non-current non-financial liabilities',\n",
       " 'Other non-financial assets',\n",
       " 'Other non-financial liabilities',\n",
       " 'Other property, plant and equipment',\n",
       " 'Other property, plant and equipment [member]',\n",
       " 'Other provisions',\n",
       " 'Other provisions [abstract]',\n",
       " 'Other reserves',\n",
       " 'Other revenue',\n",
       " 'Other reversals of provisions',\n",
       " 'Other short-term employee benefits',\n",
       " 'Other current provisions',\n",
       " 'Other tax effects for reconciliation between accounting profit and tax expense (income)',\n",
       " 'Other tax rate effects for reconciliation between accounting profit and tax expense (income)',\n",
       " 'Payments for premiums and claims, annuities and other policy benefits',\n",
       " 'Payments from contracts held for dealing or trading purpose',\n",
       " 'Payments of other equity instruments',\n",
       " \"Payments to acquire or redeem entity's shares\",\n",
       " 'Payments to and on behalf of employees',\n",
       " 'Payments to suppliers for goods and services',\n",
       " 'Period covered by financial statements',\n",
       " 'Plan assets, at fair value',\n",
       " 'Post-employment benefit expense, defined contribution plans',\n",
       " 'Price index movements',\n",
       " 'Proceeds from government grants, classified as financing activities',\n",
       " 'Proceeds from government grants, classified as investing activities',\n",
       " 'Proceeds from issuing other equity instruments',\n",
       " 'Proceeds from issuing shares',\n",
       " 'Proceeds from sales of other long-term assets, classified as investing activities',\n",
       " 'Proceeds from sales of intangible assets, classified as investing activities',\n",
       " 'Proceeds from sales of property, plant and equipment, classified as investing activities',\n",
       " 'Profit (loss)',\n",
       " 'Profit (loss) [abstract]',\n",
       " 'Profit (loss), attributable to [abstract]',\n",
       " 'Profit (loss), attributable to non-controlling interests',\n",
       " 'Profit (loss), attributable to ordinary equity holders of parent entity [abstract]',\n",
       " 'Profit (loss), attributable to owners of parent',\n",
       " 'Profit (loss) before tax',\n",
       " 'Profit (loss) from continuing operations',\n",
       " 'Profit (loss) from discontinued operations',\n",
       " 'Disclosure of operating segments [abstract]',\n",
       " 'Property, plant and equipment',\n",
       " 'Property, plant and equipment [abstract]',\n",
       " 'Property, plant and equipment, expenditures recognised in course of its construction',\n",
       " 'Property, plant and equipment, gross carrying amount of fully depreciated assets still in use',\n",
       " 'Property, plant and equipment, revaluation [abstract]',\n",
       " 'Property, plant and equipment, revaluation surplus',\n",
       " 'Property, plant and equipment, temporarily idle',\n",
       " 'Provision for decommissioning, restoration and rehabilitation costs',\n",
       " 'Provision for decommissioning, restoration and rehabilitation costs [abstract]',\n",
       " 'Provisions for employee benefits',\n",
       " 'Provision used, other provisions',\n",
       " 'Purchase of intangible assets, classified as investing activities',\n",
       " 'Purchase of other long-term assets, classified as investing activities',\n",
       " 'Purchase of property, plant and equipment, classified as investing activities',\n",
       " 'Range of estimates within which fair value is likely to lie for biological assets, at cost',\n",
       " 'Range of estimates within which fair value is likely to lie for investment property, cost model',\n",
       " 'Raw materials and consumables used',\n",
       " 'Receipts from contracts held for dealing or trading purposes',\n",
       " 'Receipts from premiums and claims, annuities and other policy benefits',\n",
       " 'Receipts from royalties, fees, commissions and other revenue',\n",
       " 'Receipts from sales of goods and rendering of services',\n",
       " 'Recipes, formulae, models, designs and prototypes',\n",
       " 'Recipes, formulae, models, designs and prototypes [member]',\n",
       " 'Reclassification adjustments on available-for-sale financial assets, before tax',\n",
       " 'Reclassification adjustments on available-for-sale financial assets, net of tax',\n",
       " 'Reclassification adjustments on cash flow hedges, before tax',\n",
       " 'Reclassification adjustments on cash flow hedges, net of tax',\n",
       " 'Reconciliation of accounting profit multiplied by applicable tax rates [abstract]',\n",
       " 'Reconciliation of average effective tax rate and applicable tax rate [abstract]',\n",
       " 'Reconciliation of changes in biological assets [abstract]',\n",
       " 'Reconciliation of changes in goodwill [abstract]',\n",
       " 'Reconciliation of changes in intangible assets other than goodwill [abstract]',\n",
       " 'Reconciliation of changes in investment property [abstract]',\n",
       " 'Reconciliation of changes in other provisions [abstract]',\n",
       " 'Reconciliation of changes in property, plant and equipment [abstract]',\n",
       " 'Redesignated [member]',\n",
       " 'Redesignated amount [member]',\n",
       " 'Redesignated financial asset as available-for-sale',\n",
       " 'Redesignated financial asset as at fair value through profit or loss',\n",
       " 'Redesignated financial liability as at fair value through profit or loss',\n",
       " 'Rental income from investment property',\n",
       " 'Repayments of borrowings, classified as financing activities',\n",
       " 'Description of restrictions on access to assets in funds',\n",
       " 'Restructuring provision',\n",
       " 'Restructuring provision [abstract]',\n",
       " 'Retained earnings',\n",
       " 'Revaluation increase (decrease), intangible assets other than goodwill',\n",
       " 'Revaluation increase (decrease), property, plant and equipment',\n",
       " 'Revaluation of intangible assets [abstract]',\n",
       " 'Revenue',\n",
       " 'Revenue [abstract]',\n",
       " 'Revenue from construction contracts',\n",
       " 'Dividend income',\n",
       " 'Interest income',\n",
       " 'Revenue from rendering of services',\n",
       " 'Royalty income',\n",
       " 'Revenue from sale of goods',\n",
       " 'Reversal of inventory write-down',\n",
       " 'Reversal of provisions for cost of restructuring',\n",
       " 'Description of segment in which non-current asset or disposal group held for sale is presented',\n",
       " 'Disclosure of geographical areas [abstract]',\n",
       " 'Disclosure of products and services [abstract]',\n",
       " 'Sensitivity analysis for types of market risk [text block]',\n",
       " 'Profit or loss [abstract]',\n",
       " 'Share of profit (loss) of associates and joint ventures accounted for using equity method',\n",
       " 'Share premium',\n",
       " 'Short-term deposits, classified as cash equivalents',\n",
       " 'Short-term investments, classified as cash equivalents',\n",
       " 'Current legal proceedings provision',\n",
       " 'Current miscellaneous other provisions',\n",
       " 'Current onerous contracts provision',\n",
       " 'Current provision for decommissioning, restoration and rehabilitation costs',\n",
       " 'Current restructuring provision',\n",
       " 'Current warranty provision',\n",
       " 'Statement of cash flows [abstract]',\n",
       " 'Statement of changes in equity [abstract]',\n",
       " 'Statement of comprehensive income [abstract]',\n",
       " 'Statement of financial position [abstract]',\n",
       " \"Summary quantitative data about entity's exposure to risk [text block]\",\n",
       " 'Surplus (deficit) in plan',\n",
       " 'Tangible exploration and evaluation assets',\n",
       " 'Tangible exploration and evaluation assets [member]',\n",
       " 'Tax benefit arising from previously unrecognised tax loss, tax credit or temporary difference of prior period used to reduce current tax expense',\n",
       " 'Tax benefit arising from previously unrecognised tax loss, tax credit or temporary difference of prior period used to reduce deferred tax expense',\n",
       " 'Tax effect from change in tax rate',\n",
       " 'Tax effect of expense not deductible in determining taxable profit (tax loss)',\n",
       " 'Tax effect of foreign tax rates',\n",
       " 'Tax effect of revenues exempt from taxation',\n",
       " 'Tax effect of tax losses',\n",
       " 'Tax expense (income) at applicable tax rate',\n",
       " 'Tax expense (income) relating to changes in accounting policies and errors included in profit or loss',\n",
       " 'Tax rate effect from change in tax rate',\n",
       " 'Tax rate effect of expense not deductible in determining taxable profit (tax loss)',\n",
       " 'Tax rate effect of foreign tax rates',\n",
       " 'Tax rate effect of revenues exempt from taxation',\n",
       " 'Tax rate effect of tax losses',\n",
       " 'Termination benefits expense',\n",
       " 'Description of timing and reason for transfer between financial liabilities and equity attributable to change in redemption prohibition',\n",
       " 'Trade and other payables',\n",
       " 'Trade and other payables [abstract]',\n",
       " 'Trade and other receivables',\n",
       " 'Trade and other receivables [abstract]',\n",
       " 'Transfer between financial liabilities and equity attributable to change in redemption prohibition',\n",
       " 'Treasury shares',\n",
       " 'Unrecognised share of losses of associates',\n",
       " 'Unused provision reversed, other provisions',\n",
       " 'Unused tax credits for which no deferred tax asset recognised',\n",
       " 'Unused tax losses for which no deferred tax asset recognised',\n",
       " 'Vehicles',\n",
       " 'Vehicles [member]',\n",
       " 'Wages and salaries',\n",
       " 'Warranty provision',\n",
       " 'Warranty provision [abstract]',\n",
       " 'Other work performed by entity and capitalised',\n",
       " 'Write-downs (reversals of write-downs) of inventories',\n",
       " 'Write-downs (reversals of write-downs) of property, plant and equipment',\n",
       " 'Disclosure of major customers [abstract]',\n",
       " 'Aggregate adjustment to carrying amounts of investments reported under previous GAAP',\n",
       " 'Aggregate deemed cost of investments for which deemed cost is fair value',\n",
       " 'Aggregate deemed cost of investments for which deemed cost is previous GAAP carrying amount',\n",
       " 'Equity reclassified into financial liabilities',\n",
       " 'Expenses on financial assets reclassified out of financial assets at fair value through profit or loss recognised in profit or loss',\n",
       " 'Explanation of facts and circumstances indicating rare situation for reclassification out of financial assets at fair value through profit or loss',\n",
       " 'Fair value gains (losses) on financial assets reclassified out of available-for-sale financial assets not recognised in other comprehensive income',\n",
       " 'Fair value gains (losses) on financial assets reclassified out of available-for-sale financial assets recognised in other comprehensive income',\n",
       " 'Fair value gains (losses) on financial assets reclassified out of financial assets at fair value through profit or loss not recognised in profit or loss',\n",
       " 'Fair value gains (losses) on financial assets reclassified out of financial assets at fair value through profit or loss recognised in profit or loss',\n",
       " 'Finance income',\n",
       " 'Financial assets reclassified out of available-for-sale financial assets, at fair value',\n",
       " 'Financial assets reclassified out of available-for-sale financial assets, carrying amount',\n",
       " 'Financial assets reclassified out of financial assets at fair value through profit or loss, at fair value',\n",
       " 'Financial assets reclassified out of financial assets at fair value through profit or loss, carrying amount',\n",
       " 'Financial liabilities reclassified into equity',\n",
       " 'Gains (losses) on financial assets reclassified out of financial assets at fair value through profit or loss recognised in profit or loss',\n",
       " 'Income on financial assets reclassified out of financial assets at fair value through profit or loss recognised in profit or loss',\n",
       " 'Increase (decrease) in cash and cash equivalents before effect of exchange rate changes',\n",
       " 'Length of life of limited life entity',\n",
       " 'Trade and other non-current receivables',\n",
       " 'Other income (expense) from subsidiaries, jointly controlled entities and associates',\n",
       " 'Reclassification into available-for-sale financial assets',\n",
       " 'Reclassification into held-to-maturity investments',\n",
       " 'Reclassification into loans and receivables',\n",
       " 'Reclassification out of available-for-sale financial assets',\n",
       " 'Reclassification out of financial assets at fair value through profit or loss',\n",
       " 'Reclassification out of held-to-maturity investments',\n",
       " 'Reclassification out of loans and receivables',\n",
       " 'Trade and other current receivables',\n",
       " 'Disclosure of operating segments [table]',\n",
       " 'Disclosure of products and services [table]',\n",
       " 'Disclosure of geographical areas [table]',\n",
       " 'Disclosure of major customers [table]',\n",
       " 'Financial effect of transition from previous GAAP to IFRSs [axis]',\n",
       " 'Geographical areas [axis]',\n",
       " 'Continuing and discontinued operations [axis]',\n",
       " 'Previously stated [member]',\n",
       " 'Increase (decrease) due to corrections of prior period errors [member]',\n",
       " 'Increase (decrease) due to changes in accounting policy [member]',\n",
       " 'Currently stated [member]',\n",
       " 'Previous GAAP [member]',\n",
       " 'Effect of transition to IFRSs [member]',\n",
       " 'IFRSs [member]',\n",
       " 'Geographical areas [member]',\n",
       " 'Continuing operations [member]',\n",
       " 'Discontinued operations [member]',\n",
       " 'Aggregate continuing and discontinued operations [member]',\n",
       " 'Reportable segments [member]',\n",
       " 'Products and services [member]',\n",
       " 'Products and services [axis]',\n",
       " 'Consolidated [member]',\n",
       " 'Separate [member]',\n",
       " 'Consolidated and separate financial statements [axis]',\n",
       " 'Disposal groups classified as held for sale [member]',\n",
       " 'Customers [member]',\n",
       " 'Major customers [axis]',\n",
       " 'Retrospective application and retrospective restatement [axis]',\n",
       " 'Increase (decrease) in dividends payable through change in fair value of non-cash assets held for distribution to owners',\n",
       " 'Dividends payable, non-cash assets distributions',\n",
       " 'Description of nature of non-cash assets held for distribution to owners declared before financial statements authorised for issue',\n",
       " 'Non-cash assets declared for distribution to owners before financial statements authorised for issue',\n",
       " 'Non-cash assets declared for distribution to owners before financial statements authorised for issue, at fair value',\n",
       " 'Borrowings',\n",
       " 'Current borrowings',\n",
       " 'Current portion of non-current borrowings',\n",
       " 'All other segments [member]',\n",
       " 'Operating segments [member]',\n",
       " 'Material reconciling items [member]',\n",
       " 'Trade and other current payables',\n",
       " 'Trade and other non-current payables',\n",
       " 'Proceeds from borrowings, classified as financing activities',\n",
       " 'Gains (losses) on financial assets at fair value through profit or loss',\n",
       " 'Gains (losses) on financial liabilities at fair value through profit or loss',\n",
       " 'Gains (losses) on financial assets at fair value through profit or loss, classified as held for trading',\n",
       " 'Gains (losses) on financial liabilities at fair value through profit or loss, classified as held for trading',\n",
       " 'Description of amounts of potential income tax consequences practicably determinable',\n",
       " 'Description of basis of accounting for transactions between reportable segments',\n",
       " \"Description of nature of differences between measurements of reportable segments' profits or losses and entity's profit or loss before income tax expense or income and discontinued operations\",\n",
       " \"Description of nature of differences between measurements of reportable segments' assets and entity's assets\",\n",
       " \"Description of nature of differences between measurements of reportable segments' liabilities and entity's liabilities\",\n",
       " 'Description of nature of changes from prior periods in measurement methods used to determine reported segment profit or loss and effect of those changes on measure of segment profit or loss',\n",
       " 'Description of nature and effect of any asymmetrical allocations to reportable segments',\n",
       " 'Description of criteria used to distinguish investment property from owner-occupied property and from property held for sale in ordinary course of business',\n",
       " 'Description of extent to which fair value of investment property is based on valuation by independent valuer',\n",
       " 'Direct operating expense from investment property not generating rental income',\n",
       " 'Reserve of cash flow hedges',\n",
       " 'Reserve of exchange differences on translation',\n",
       " 'Revaluation surplus',\n",
       " 'Disclosure of detailed information about business combination [table]',\n",
       " 'Business combinations [axis]',\n",
       " 'Aggregated individually immaterial business combinations [member]',\n",
       " 'Name of acquiree',\n",
       " 'Description of acquiree',\n",
       " 'Percentage of voting equity interests acquired',\n",
       " 'Description of primary reasons for business combination',\n",
       " 'Description of how acquirer obtained control of acquiree',\n",
       " 'Description of factors that make up goodwill recognised',\n",
       " 'Consideration transferred, acquisition-date fair value',\n",
       " 'Cash transferred',\n",
       " 'Other tangible or intangible assets transferred',\n",
       " 'Liabilities incurred',\n",
       " 'Equity interests of acquirer',\n",
       " 'Number of instruments or interests issued or issuable',\n",
       " 'Description of method of measuring fair value of instruments or interests',\n",
       " 'Description of arrangement for contingent consideration arrangements and indemnification assets',\n",
       " 'Description of basis for determining amount of payment for contingent consideration arrangements and indemnification assets',\n",
       " 'Description of estimate of range of undiscounted outcomes from contingent consideration arrangements and indemnification assets',\n",
       " 'Description of explanation of fact and reasons why range of outcomes from contingent consideration arrangements and indemnification assets cannot be estimated',\n",
       " 'Explanation of fact that maximum amount of payment for contingent consideration arrangements and indemnification assets is unlimited',\n",
       " 'Fair value of acquired receivables',\n",
       " 'Gross contractual amounts receivable for acquired receivables',\n",
       " 'Best estimate at acquisition date of contractual cash flows not expected to be collected for acquired receivables',\n",
       " 'Description of reasons why liability cannot be measured reliably',\n",
       " 'Goodwill expected to be deductible for tax purposes',\n",
       " 'Description of transaction recognised separately from acquisition of assets and assumption of liabilities in business combination',\n",
       " 'Description of line item in statement of comprehensive income in which gain in bargain purchase transaction is recognised',\n",
       " 'Description of reasons why bargain purchase transaction resulted in gain',\n",
       " 'Non-controlling interest in acquiree recognised at acquisition date',\n",
       " 'Description of measurement basis for non-controlling interest in acquiree recognised at acquisition date',\n",
       " 'Description of valuation techniques and significant inputs used to measure non-controlling interest in acquiree measured at fair value',\n",
       " 'Acquisition-date fair value of equity interest in acquiree held by acquirer immediately before acquisition date',\n",
       " 'Revenue of acquiree since acquisition date',\n",
       " 'Profit (loss) of acquiree since acquisition date',\n",
       " 'Revenue of combined entity as if combination occurred at beginning of period',\n",
       " 'Profit (loss) of combined entity as if combination occurred at beginning of period',\n",
       " 'Description of reasons why initial accounting for business combination is incomplete',\n",
       " 'Description of assets, liabilities, equity interests or items of consideration for which initial accounting is incomplete',\n",
       " 'Description of nature of any measurement period adjustments recognised for particular assets, liabilities, non-controlling interests or items of consideration',\n",
       " 'Explanation of any changes in recognised amounts of contingent consideration',\n",
       " 'Description of valuation techniques and key model inputs used to measure contingent consideration',\n",
       " 'Goodwill derecognised without having previously been included in disposal group classified as held for sale',\n",
       " \"Gain (loss) that relates to identifiable assets acquired or liabilities assumed in business combination and is of such size, nature or incidence that disclosure is relevant to understanding combined entity's financial statements\",\n",
       " \"Explanation of gain or loss that relates to identifiable assets acquired or liabilities assumed in business combination and is of such size, nature or incidence that disclosure is relevant to understanding combined entity's financial statements\",\n",
       " 'Explanation of fact and explanation of why disclosure of information on revenues and profit or loss is impracticable',\n",
       " 'Explanation of which disclosures could not be made and reasons why they cannot be made if initial accounting for business combination is incomplete at time financial statements are authorised for issue',\n",
       " 'Business combinations [member]',\n",
       " 'Disclosure of detailed information about business combination [abstract]',\n",
       " 'Number of shares authorised',\n",
       " 'Number of shares issued and fully paid',\n",
       " 'Number of shares issued but not fully paid',\n",
       " 'Par value per share',\n",
       " 'Rights, preferences and restrictions attaching to class of share capital',\n",
       " 'Number of shares in entity held by entity or by its subsidiaries or associates',\n",
       " 'Number of shares reserved for issue under options and contracts for sale of shares',\n",
       " 'Adjustments for income tax expense',\n",
       " 'Adjustments for depreciation and amortisation expense',\n",
       " 'Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss',\n",
       " 'Adjustments for share-based payments',\n",
       " 'Adjustments for fair value losses (gains)',\n",
       " 'Description of objectives, policies and processes for managing risks arising from insurance contracts and methods used to manage those risks',\n",
       " 'Disclosure of insurance risk [text block]',\n",
       " 'Disclosure of sensitivity to insurance risk [text block]',\n",
       " 'Sensitivity analysis to insurance risk',\n",
       " 'Qualitative information about sensitivity and information about those terms and conditions of insurance contracts that have material effect',\n",
       " 'Description of concentrations of insurance risk',\n",
       " 'Disclosure of actual claims compared with previous estimates [text block]',\n",
       " 'Disclosure of credit risk of insurance contracts [text block]',\n",
       " 'Disclosure of liquidity risk of insurance contracts [text block]',\n",
       " 'Disclosure of market risk of insurance contracts [text block]',\n",
       " 'Disclosure of maturity analysis for derivative financial liabilities [text block]',\n",
       " 'Reserve of gains and losses on remeasuring available-for-sale financial assets',\n",
       " 'Current provisions',\n",
       " 'Non-current provisions',\n",
       " 'Provisions',\n",
       " 'Disclosure of temporary difference, unused tax losses and unused tax credits [text block]',\n",
       " 'Description of accounting policy for investment in associates [text block]',\n",
       " 'Description of accounting policy for investments in joint ventures [text block]',\n",
       " 'Fair value of investments in joint ventures for which there are quoted market prices',\n",
       " 'Gains (losses) on financial assets at amortised cost',\n",
       " 'Disclosure of comparative information prepared under previous GAAP [abstract]',\n",
       " 'Disclosure of comparative information prepared under previous GAAP [table]',\n",
       " 'Non-current receivables due from related parties',\n",
       " 'Receivables due from related parties',\n",
       " 'Current receivables due from related parties',\n",
       " 'Trade payables',\n",
       " 'Payables to related parties',\n",
       " 'Current trade payables',\n",
       " 'Current payables to related parties',\n",
       " 'Non-current trade payables',\n",
       " 'Non-current payables to related parties',\n",
       " 'Trade and other non-current receivables [abstract]',\n",
       " 'Trade and other current payables [abstract]',\n",
       " 'Trade and other non-current payables [abstract]',\n",
       " 'Trade and other current receivables [abstract]',\n",
       " 'Principal place of business',\n",
       " 'Income taxes paid (refund)',\n",
       " 'Explanation of reason why it is impracticable to determine amounts for correction related to prior period errors',\n",
       " 'Explanation of reason why it is impracticable to determine amounts of adjustments related to change in accounting policy',\n",
       " 'Income taxes paid (refund) [abstract]',\n",
       " 'Explanation of nature of requirement in IFRS and conclusion why requirement is in conflict with objective of financial statements set out in Framework',\n",
       " 'Explanation of adjustments that would be necessary to achieve fair presentation',\n",
       " 'Accruals classified as current',\n",
       " 'Accruals classified as non-current',\n",
       " 'Accruals',\n",
       " 'Description of nature of transferred financial assets that are not derecognised in their entirety',\n",
       " 'Description of nature of risks and rewards of ownership to which entity is exposed',\n",
       " 'Assets that entity continues to recognise',\n",
       " 'Current provisions [abstract]',\n",
       " 'Non-current provisions [abstract]',\n",
       " 'Provisions [abstract]',\n",
       " 'Issued capital [member]',\n",
       " 'Share premium [member]',\n",
       " 'Treasury shares [member]',\n",
       " 'Other equity interest [member]',\n",
       " 'Retained earnings [member]',\n",
       " 'Equity attributable to owners of parent [member]',\n",
       " 'Non-controlling interests [member]',\n",
       " 'Components of equity [axis]',\n",
       " 'Statement of changes in equity [table]',\n",
       " 'Disclosure of detailed information about property, plant and equipment [abstract]',\n",
       " 'Disclosure of detailed information about property, plant and equipment [table]',\n",
       " 'Classes of property, plant and equipment [axis]',\n",
       " 'Disclosure of detailed information about intangible assets [abstract]',\n",
       " 'Disclosure of detailed information about intangible assets [table]',\n",
       " 'Classes of intangible assets other than goodwill [axis]',\n",
       " 'Disclosure of reconciliation of changes in biological assets [abstract]',\n",
       " 'Disclosure of reconciliation of changes in biological assets [table]',\n",
       " 'Measurement [axis]',\n",
       " 'Disclosure of other provisions [abstract]',\n",
       " 'Disclosure of other provisions [table]',\n",
       " 'Classes of other provisions [axis]',\n",
       " 'Description of nature of obligation, other provisions',\n",
       " 'Description of expected timing of outflows, other provisions',\n",
       " 'Indication of uncertainties of amount or timing of outflows, other provisions',\n",
       " 'Asset recognised for expected reimbursement, other provisions',\n",
       " 'Expected reimbursement, other provisions',\n",
       " 'Disclosure of detailed information about investment property [abstract]',\n",
       " 'Disclosure of detailed information about investment property [table]',\n",
       " 'Disclosure of defined benefit plans [abstract]',\n",
       " 'Disclosure of defined benefit plans [table]',\n",
       " 'Defined benefit plans [axis]',\n",
       " 'Disclosure of fair values of items used as deemed cost [table]',\n",
       " 'Fair value as deemed cost [axis]',\n",
       " 'Aggregate adjustment to carrying amounts reported under previous GAAP [member]',\n",
       " 'Aggregate of fair values [member]',\n",
       " 'Property, plant and equipment fair value used as deemed cost',\n",
       " 'Intangible asset fair value used as deemed cost',\n",
       " 'Investment property fair value used as deemed cost',\n",
       " 'Disclosure of redesignated financial assets and liabilities [table]',\n",
       " 'Redesignation [axis]',\n",
       " 'Disclosure of impairment loss and reversal of impairment loss [table]',\n",
       " 'Goodwill [member]',\n",
       " 'Other impaired assets [member]',\n",
       " 'Disclosure of financial assets [abstract]',\n",
       " 'Disclosure of financial assets [table]',\n",
       " 'Financial assets',\n",
       " 'Disclosure of financial liabilities [abstract]',\n",
       " 'Disclosure of financial liabilities [table]',\n",
       " 'Financial liabilities',\n",
       " 'Financial assets at fair value through profit or loss, classified as held for trading',\n",
       " 'Financial assets at fair value through profit or loss',\n",
       " 'Held-to-maturity investments',\n",
       " 'Loans and receivables',\n",
       " 'Financial liabilities at fair value through profit or loss that meet definition of held for trading',\n",
       " 'Equity [member]',\n",
       " 'Property, plant and equipment [member]',\n",
       " 'Intangible assets other than goodwill [member]',\n",
       " 'Other provisions [member]',\n",
       " 'Investment property [member]',\n",
       " 'Fair value model [member]',\n",
       " 'Defined benefit plans [member]',\n",
       " 'Warranty provision [member]',\n",
       " ...]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "L2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
